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Health-led approach to drug and alcohol use 
 
Reducing Harm, Supporting Recovery - a health-led approach to drug and alcohol use in 
Ireland 2017-2025 is a new departure for Ireland’s policy on drugs, reflecting a change in 
attitudes to substance misuse.   It promotes a more compassionate and humane approach to 
people who use drugs, with addiction treated first and foremost as a health issue.    It adopts a 
health-led approach that prioritises achieving better health and social outcomes for people 
affected by substance misuse. It involves government departments, statutory bodies and civil 
society, including individuals, families and communities affected by drug and alcohol use.   
 
The strategy maintains the balanced approach of its predecessors, with a focus on reducing the 
demand for drugs and the harms associated with drug use, and at the same time promoting 
strategies to reduce the supply of drugs for harmful use.    
 
The vision of Reducing Harm, Supporting Recovery is for a healthier and safer Ireland.  
Reducing the harms caused to individuals, families and communities by substance use is a core 
goal of the strategy.  Ensuring that every person is empowered to improve their health and 
wellbeing and quality of life is a further important goal.  The vision highlights the importance 
of empowering people at the individual level and building strong communities for health and 
wellbeing.   
 
The Programme for Government, Our Shared Future, endorses the health-led approach to drug 
and alcohol use.  By treating the use of substances as a public health issue, rather than solely 
as a criminal justice issue, we can better help individuals, families and communities.  It also 
notes the increase in the prevalence of drug use in recent years, which affects people from all 
walks of life.  
  
Content of the mid-term review 
Reducing Harm, Supporting Recovery maps out a 50-point action plan with integrated actions 
and holistic interventions up to 2020.   It provides the opportunity for the development of 






The Mid-term review is informed by: 
i. Examination of progress of the actions in the strategy (traffic light format); 
ii. Stakeholder feedback to include a review of oversight structures; 
iii. Focused policy assessment of expenditure on drug and alcohol services; 
iv. Data on trends and indicators on drug and alcohol use; and 
v. Rapid assessment of impact of COVID-19 on drug and alcohol services. 
 
The review is timely and will allow policy to take account of the impact of COVID-19 on 
people who use drugs and on drugs and alcohol services and to plan accordingly for the 
remaining years of the strategy.  The results of the review will determine whether further 
actions need to be developed for the period 2021-2025.   
 
The development of a new priorities and actions for 2021 to 2025 will ensure the continued 
relevance of the strategy until the end of its term and will require continued collaborative 
partnership between all relevant sectors and interests.  This will be informed by the following: 
• European Union Drugs Strategy 2021-2025 
• Sláintecare Implementation Strategy & Action Plan 2021 — 2023 & Healthy Ireland 
Strategic Action Plan 2021–2025 




(i) Progress in implementing the strategic action plan 2017-2020  
 
Reducing Harm, Supporting Recovery emphasises a health-led, whole-of-government response 
to drug and alcohol use, based on providing person-centred services that promote rehabilitation 
and recovery.   The vision of the strategy is for   
A healthier and safer Ireland, where public health and safety is protected and the harms 
caused to individuals, families and communities by substance misuse are reduced and 
every person affected by substance use is empowered to improve their health and 
wellbeing and quality of life.   
 
To realise this vision, the strategy identifies five strategic goals and 50 actions with 101 sub-
actions, to be delivered over the initial four year period 2017-2020.  The goals and their related 
actions can be summarised as follows: 
Goal 1 aims to promote and protect health and wellbeing and contains 11 actions, 
comprising 22 sub-actions; 
Goal 2 seeks to minimise the harms caused by the use and misuse of substances and 
promote rehabilitation and recovery.  This goal is made up of 19 actions, and 49 sub-
actions;  
Goal 3 aims to address the harms of drug markets and reduce access to drugs for harmful 
use and comprises 8 actions and 13 sub-actions;  
Goal 4 aims to support participation of individuals, families and communities and 
comprises 6 actions; and  
Goal 5 seeks to develop sound and comprehensive evidence-informed policies and 
actions.  5 actions comprising 11 sub-actions are identified to realise this goal. 
 
There is a further action to strengthen the performance of the strategy which is comprised of 6 
sub-actions.   
 
Report outlining the progress during 2020  
Lead departments / agencies for each action and sub-action contained in the strategy reported 
on the work undertaken during 2020 and provided their assessment of the progress in delivering 




The 2020 progress report is based on this information.  Analysis indicates that 25 actions have 
been delivered upon, either completely or broadly on track.  A further 20 actions are 
progressing but with a minor or major delivery issue.   The table below indicates the status of 
the actions across the various goals.     
 
  Status of Actions 
Theme Black Green Amber Red Blue 
Goal One: Promote and Protect Health and 
Wellbeing 
 
2 3 2 4 
Goal Two:  Minimise the harms caused by the 
use and misuse of substances and promote 
rehabilitation and recovery. 
 
6 5 3 3 
Goal Three: Address the harms of drug markets 
and reduce access to drugs for harmful use. 
 
3 1 1 2 
Goal Four: Support participation of individuals, 





Goal Five: Develop sound and comprehensive 









The full progress report is attached at appendix 1.  
 
 
(ii) Stakeholder feedback to include a review of oversight structures 
As part of the review, a stakeholder engagement was undertaken.  22 stakeholders participated 
in 10 engagement sessions.   A list of the stakeholders is attached in appendix 2.   Feedback 
was sought on the following three questions: 
1. How well is the strategy delivering on its goals? 
2. Are there specific areas/ priorities that the strategy should focus on for period 2021-
2025?  
3. Are there ways in which the structures for the delivery of the strategy could be 
improved/ strengthened? 
Also received submissions from groups outside the formal structures of the NOC 
 
The main points raised by stakeholders are set out below.  
 
There was agreement at all of the engagement meetings that the strategy has fostered a person-
centred approach which puts the needs of the person at the centre of the response.   The health-
led approach was seen as successful and many achievements under the strategy can be 
attributed to that approach.  At the same time there was acknowledgement that the health-led 
approach goes hand-in-hand with the work of law enforcement to reduce the supply/ 
availability of illicit drugs.  The health-led approach does not remove the criminal aspect and 
AGS and the Department of Justice have a role in addressing the criminal aspects of drugs 
markets and drug use and this dual aspect should be highlighted in the strategy.   
 
Significant successes have been achieved in relation to drug markets and seizures as a result of 
intelligence led operations spearheaded by law enforcement agencies and underpinned by 
national and international cooperation.  National co-operation between AGS, RCS and the 
HPRA and international cooperation at both AGS and RCS levels includes involvement in 
Interpol, MAOC-N, were acknowledged.   
 
There is an acknowledgement that drug markets and drugs are continuously evolving.  Keeping 
on top of new substances coming on stream and their transition is an ongoing requirement. 
Sharing of information and intelligence both nationally and internationally has been very 
useful.  The re-establishment of the Early Warning and Emerging Trends subcommittee has 
proven to be very beneficial and involves a wide range of membership.   The extent at which 
co-operation is taking place is at an international level is also very useful. It was suggested that 
 
 
the “International Drugs Issues Group” could be reinstated.  Part of the work of this group 
could be to enumerate Ireland’s involvement at international levels and identify areas for 
further connections.     
 
Many people who use drugs problematically come into contact with the criminal justice system 
and acquire criminal convictions, either directly or indirectly related to their drug use.   The 
Govt decision agreeing an alternative approach was seen as positive, however it was felt that 
progress on the implementation of the health diversion programme was slow.   The programme 
for Govt commitment to review the Health Diversion programme, to ensure that it is meeting 
all of its aims, following the first full year of implementation, and make any necessary changes, 
was welcomed. 
 
In addition, Ireland provides for drugs treatment courts to assist offenders with drug-related 
problems.  The Minister for Justice and Equality is examining options as a way forward for the 
operation of the Drug Treatment Court.  The matter will be progressed alongside wider justice 
reforms that are also under consideration, such as the proposal to establish a Community Court. 
An independent review of the Drug Treatment Court could inform the Minister’s deliberations, 
and the initiative should continue to be supported in the meantime.  Future actions in the 
strategy should be aligned with the outcome of this review.  
 
Alcohol 
Reducing Harm Supporting Recovery sets out the response to drug and alcohol use in Ireland.  
However, the feedback from stakeholder was that the strategy, and in particular the action plan 
for the period 2017 to 2020, did not bring as much focus to alcohol use as it did to other drugs.  
A much greater focus on alcohol was required for the upcoming period.   
 
Addressing alcohol issues requires a co-ordinated ‘whole-of-government’ approach. The scale 
of the societal problem around alcohol is such that it now needs a dedicated resource to drive 
change.  The Public Health Alcohol Act and its provisions needs to be fully implemented. 
Treatment services need to be able to cater for the needs of all those who use drugs and alcohol, 






Alignment with other strategies 
It was outlined that there can be a lot of facets to a person who uses drugs, and that the national 
drugs strategy and other strategies may not always recognise the intersectionality and differing 
needs of each individual.  People who use drugs are not a homogenous group and their needs 
can be varied, multifaceted and complex.  Government policies have been developing over the 
period since the strategy was launched and there is a strong argument to be made to ensure that 
policies are aligned as much as possible.  By ensuring alignment across strategies, this will 
ensure a holistic, whole-of-Government approach to addressing the varying and differing needs 
of the individual. 
 
The strategic action plan 2017-2020 explicitly references the joint commitment of the 
Department of Housing and Local Government and the Department of Health to addressing the 
needs of people who are homeless and have addiction issues.  Stakeholders proposed that this 
approach might be applied to other strategies, so that strategies reflect the same aims, have 
joint commitments and complement each other rather than duplicate issues.  The following 
were identified as strategies with which RHSR should be aligned:   
o EU Drug Strategy 
o Dept of Justice strategies i.e Youth Strategy, Garda Youth Diversion Projects  
o Healthy Ireland Strategic action plan is in the process of being refreshed for the 
period 2021-2025, actions within RHSR will be reflected in this refresh. The 
action plan will reflect a collection of measures across a number of strategies 
which impact on the health and wellbeing of the population.     
o Social Inclusion Community Activation Programme (SICAP): Department of 
Rural and Community Development are in early planning stages of the next 
SICAP and will examine new SICAP models for opportunities to align with 
Reducing Harm, Supporting Recovery. 
o Better Outcomes Brighter Futures.  
o Sharing the Vision. 
o Women’s health task force & strategy. 
 
Collaboration 
A critical element of the national drug strategy is the co-operation and collaboration between 
depts and agencies and services.  Overall, the strategy has facilitated improved collaboration 
and engagement in progressing responses to substance misuse. It has supported engagement 
 
 
with a range of statutory, voluntary and community-based organisations in progressing areas 
including care-planning, addressing gaps in services, assessment, evidenced based 
interventions and sharing of information / training to staff. 
 
There have been some great examples where the flexibility, collaboration and interagency co-
operation that has developed has been essential in progressing the actions in the strategy.   That 
collaborative approach has provided flexibility to adapt to changing circumstance - the 
response to the COVID-19 pandemic being a prime example.   
 
Our stakeholders have identified good collaboration as being essential in providing:- 
• healthier and safer communities, 
• better communication, 
• improving access to support services, 
• providing support to vulnerable groups, and 
• providing support services according to local needs. 
 
Some examples of collaboration working well include the joint commitment of Department of 
Housing and Local Government and the Department of Health on addressing homeless issues 
which is explicitly referenced in the RHSR Action Plan and remains on track.  The joint 
engagement and parallel funding commitments in 2020/2021 in addressing homelessness is 
working well.   Excellent collaboration between addiction services, substance misuse services 
and homeless services in recognition of the higher risks for people who are homeless to the 
effects of COVID-19, illustrates the impact of a collaborative approach – people who are 
homeless have been “protected” from the worst effects of Covid. 
 
Tusla coordinates Child and Family Support Networks which is a collaborative approach in 
local areas for improving access to support services- no wrong door- and coordinating Meitheal 
Early Intervention Practice Model.  
 
Reducing Harm Supporting Recovery adopts a health-led approach to the issue of substance 
misuse but recognises there must be a policing/ enforcement role in the strategy in recognition 
of the significant developments taking place.  The strategy places an emphasis on community 
safety statements, and the Commission on the Future of Policing in Ireland recognised 
 
 
community safety is not just the responsibility of An Garda Síochána and requires a multi-
sectoral approach, strong inter-agency collaboration and community engagement with a key 
role for health and social services, as well as other sectors of society.  This is very much the 
approach envisioned in the new Policing and Community Safety bill.  
 
In addition, there is an opportunity to learn from and build on the experience of Local 
Community Policing Fora in responding to the impact of the drugs trade on communities. 
 
The success of investigation into the movement of drugs can in part be attributed to 
collaboration with other law enforcement agencies, including internationally. An Garda 
Síochána and Revenue’s Custom Service have gained intelligence through EU colleagues and 
this collaboration has been hugely important and beneficial.   
 
The Early Warning and Emerging Trends (EWET) subcommittee, chaired by the Department 
of Health, brings together a wide range of stakeholders.  The subcommittee is important and 
very effective and provides a good forum for sharing information and signposting of new trends 
and emerging drugs and pattern of drug use.   
 
Huge amount of development across Ireland may not have been possible without the Drug and 
Alcohol Task Forces (DATFs). Completely new services have emerged through the taskforce 
process, bringing many people and experience together, to reconfigure services to work better 
with better outcomes for people on the ground and prioritising services according to local 
needs.  The 12 strategic initiatives and the DRIVE initiative have progressed greatly despite 
Covid. All the taskforces and communities and services have come together to make great 
progress. 
 
Coordination and collaboration arising from the response to the pandemic has been very 
beneficial.  This collaborative approach could be enhanced in the future.  Responses, initiatives 
and measures introduced in response to the COVID-19 pandemic should be continued where 
possible and appropriate. Continued support is required to sustain the current momentum of 





A key focus within the current Reducing Harm Supporting Recovery action plan is on the 
transition of children in care from care into adulthood.  This focus should continue but might 
usefully be broadened to include an interagency approach with housing, local authorities.  
 
Some stakeholders identified the following areas in which improved collaboration was needed 
or could be strengthened: - 
• Better communication 
• More participation needed from all partners   
• Increased co-operation between youth services and drug and alcohol services to address 
the gap in services for those aged 14-18  
• More collaboration and co-ordination needed across sectors 
• State agencies need to form real partnership with affected communities 
• Need to broaden the group of service users we communicate with and receive 
feedback to incorporate a broader voice. 
• Need an interdepartmental approach to addressing the drugs issue, needs Dept. of 
Justice, Dept. of Employment, Dept. of Social Welfare. 
• The National Oversight Committee is very large and fulfils its function for transparency 
in relation to key actions.  However, it is not always the most facilitative forum for 
cross–departmental and cross-agency discussion and co-ordination.   
 
COVID-19 
It was reported that impact of the COVID-19 pandemic has required adaptation and innovation 
for the delivery of services and has demonstrated that there can be effective ways of improving 
collaboration and public access to resources to respond to the diversity of needs. The specific 
example of the joint response to COVID-19 for people who are homeless and use drugs which 
illustrates the ability of the strategy to respond to COVID-19.  The work and dedication of 
many organisations had a huge effect on minimising the impact of COVID-19 on their client 
group.  Addiction services and homeless services adapted across the country very quickly to 
work and keep people safe.  Having structures and an action plan in place enabled a huge 
acceleration in key areas. 
 
It would be important to maintain this collaboration and innovation, and to continue the 
services and collaboration which were put in place during this time. 
 
 
Monitoring and Data collection 
Reducing Harm Supporting Recovery places a significant emphasis on developing sound and 
comprehensive evidence-informed policies and actions.  The strategy acknowledges that 
Ireland has good information on the substance misuse situation at a national level.  The strategy 
has brought greater focus on the need to capture data, to monitor output and outcomes, to 
measure the impact of the actions and to inform service development and delivery.   
 
Routine monitoring provides the information on the nature, extent and consequences of 
substance misuse needed to formulate evidence-informed policy, plan services and measure 
the effectiveness of the responses to this problem. Ireland’s monitoring system collects and 
analyses data on drug use in the general and school-going population, treatment demand, high-
risk drug use and on consequences, such as infectious diseases, deaths and overdose, and fulfils 
both European and national requirements. 
 
Monitoring also provides information on harm reduction measures, and on prevention, 
rehabilitation, and other demand reduction interventions. Data is gathered through special 
health surveillance systems, such as the National Drugs Treatment Reporting System 
(NDTRS), regular population surveys or studies, published evaluations and analyses. The 
HSE’s data collection systems provide information on infectious diseases, needle exchange 
and non-fatal overdoses.    
 
There is a view that there is a lack of evidence-based data to measure service provision and 
progress of the strategy, and that without defined KPIs, it is difficult to say how well actions 
are doing.  The use of currently collected data could be reviewed and strengthened to better 
inform services and measure outcomes.  An Outcomes Framework which would enable the 
identification of data relevant to the evaluation of the strategy and to understand the nature and 
quality of data sources, should be prioritised.   There is a need for more focus on measuring 
indicators, and on measuring practical outcomes on the ground.  There was a strong view that 
timely and better data collection on alcohol harm was required. 
 
There was a call for appropriate research/ data collection over the next four years to inform the 
development of the next strategy.  There was a need for further development of National Data 
Collection tools.  However, the requirement to maximise investments already made, by further 
analysing data already collected, was also identified. 
 
 
Efforts to improve the coverage of the NDTRS does not appear to have had the desired effect.  
While the NDTRS collects data on episodes of treatment, the introductions of a unique health 
identifier would allow for much greater data collection.  An examination of how data is 
provided for the NDTRS would be useful. 
 
Reducing Harm Supporting Recovery outlines the national strategy to respond to drug and 
alcohol use in Ireland.  There is very little relevant data on alcohol use, and the harms caused 
by alcohol use.   The focus of Goal 5 should be broadened to include data monitoring and 
evaluation of alcohol services specifically, and demand for alcohol services. 
 
Drug and Alcohol TaskForces 
A major factor in the success of previous strategies has been the partnership between the 
statutory, community and voluntary sectors.  Reducing Harm Supporting Recovery has 
continued with this approach.   
 
The strategy outlines the role of Drug and Alcohol Task Forces (DATFs) in coordinating local 
and regional implementation of the National Drugs Strategy.  The strategy also provided for 
the Standing Sub Committee to monitor and support the work of the DATFS with a view to 
strengthening the Task Force interagency model.   
 
DATFs play a key role in coordinating interagency action at local level and supporting 
evidence-based approaches to problem substance use, including alcohol and illegal drugs and 
have identified a need for better support in terms of their networks, governance, and sharing of 
best practice.   DATFs have a good knowledge of the needs within their area and would like to 
be more visibly involved in the actions contained in the strategy.  Taskforces would like 
consideration of how they could be more involved in the actions, as they felt that they and their 
role within the strategy has been invisible.  DATFs suggested that they could have a significant 
impact on Goal 2 of the strategy in the implementation of the actions.  DATFs could bring 
together the community, family and service users which could have a positive impact on 
communication and participation and could also assist in identifying emerging needs.  Clear 







Reducing Harm Supporting Recovery advocates for people with a dual diagnosis, i.e. co-
occurring issues with addiction and mental health.   Sharing the Vision, the national mental 
health policy, recognises that people with a dual diagnosis should have access to appropriate 
mental health services and supports, by addressing existing service gaps and developing 
stepped, integrated models of care.  
 
For dual diagnosis, the policy is transformative, as it reverses a problematic policy 
recommendation in A Vision for Change (2006). The new policy clearly states that individuals 
with co-existing mental health difficulties and addiction to either alcohol or drugs should not 
be prevented from accessing mental health services. Therefore, for people with a dual 
diagnosis, it will no longer be necessary to establish whether a mental health difficulty is the 
primary issue in order to access a community mental health team.  
 
Sharing the Vision recommends a tiered model of integrated services for people with a dual 
diagnosis, to ensure clear care pathways and improved outcomes for individuals and their 
families. Recommendations 21 & 57 from the policy specifically refer to supports for dual 
diagnosis.  
o 21: Dedicated community-based addiction service teams should be 
developed/enhanced with psychiatry input, as required, and improved access to 
mental health supports in the community should be provided to individuals with 
co-existing low-level mental health and addiction problems. 
o 57:  A tiered model of integrated service provision for individuals with a dual 
diagnosis (eg substance misuse with mental illness) should be developed to 
ensure that pathways to care are clear. 
 
The National Implementation Monitoring Committee (NIMC) Steering Committee is focusing 
on establishing the structures and processes crucial to implementation of Sharing the 
Vision. The HSE has primary responsibility for implementing the majority of the Sharing the 





A delay with progressing the National Clinical Programme for Dual Diagnosis was noted by 
many stakeholders.  However, it was also noted that the Clinical lead post was filled, and that 
work was progressing on the first draft of a Model of Care for dual diagnosis. 
 
The Dual Diagnosis Programme aims to develop a standardised evidence-based approach to 
the identification, assessment and treatment of co-morbid mental illness and substance misuse. 
The Programme will devise a model of care that outlines how adolescents and adults suspected 
of having a moderate to severe mental illness and significant substance misuse have access to 
timely mental health services nationally.  This will be delivered on a Community Healthcare 
Organisation basis. The service will be provided in an integrated manner across the HSE's 
Primary Care Division and Mental Health Service and will ensure close working relationships 
with the relevant specialities in Acute Hospital Groups, which will deal with medical co-
morbidities that may occur. 
 
HSE Mental Health Services is keen that the approach to service delivery aligns with 
Sláintecare, in that it is integrated across the many interfaces where people can present and is 
oriented towards service users, families and communities. Service user and family member 
representation from the dual diagnosis population continues to be essential to the development 
of dual diagnosis services.  
 
The HSE Addiction and Mental Health Services and Mental Health Ireland have developed a 
resource for people affected by dual diagnosis. This resource provides advice for people on 
looking after their mental health during the pandemic, including information on accessing 
mental health and addiction services.    
 
The decision that the National Oversight Committee for the national drugs strategy should be 
represented on the National Implementation Monitoring Committee for Sharing the Vision was 
welcomed and would allow for good exchange between both strategies and ensure alignment 
between actions undertaken under both strategies to address the need of the individual and any 
blocks or barriers that might emerge. 
 
Prevention and education 
Substance misuse prevention strategies are highlighted in the strategy. Targeting families, 
schools and communities are an effective way of promoting health and wellbeing among the 
 
 
general population and result in wider benefits for society in terms of savings in future health, 
social and crime costs. Prevention strategies include measures to prevent early use of alcohol 
and other drugs among young people, reduce the misuse of alcohol and other drugs, and 
minimise harm, where drug use has already started. 
 
It was acknowledged that training and education in early years is essential because it helps 
people to make better choices in life.  However, the progress on the actions on educating young 
people about the dangers of substance misuse was seen as slow and there is a need to pool 
resources and to co-ordinate all awareness-raising, educational and preventative work better 
between different organisations.  
 
A priority identified by many stakeholders was the area of Hidden Harm - the impact of 
problematic drug and alcohol use by parents and care-givers on the developmental needs and 
safety and wellbeing of children and young people: pregnancy, infancy and early childhood; 
middle childhood and adolescence.  The strategic priorities and actions for the next period 
should maintain the focus on this area, and expand the training of service providers 
 
Support for families and communities 
Building the capacity of communities to respond to the drugs situation is a key goal of RHSR. 
The Strategy recognises the term service user to include people who use healthcare services, 
their parents, guardians, carers and families, organisations and communities that represent the 
interests of people who use health and social care services, as well as potential users of 
healthcare services such as people who currently use drugs. Stakeholders recognised the 
inclusion of family members, as they may be involved in supporting a loved one with a drug 
problem and may be service users in their own right, as a positive approach. 
 
Addressing the harmful aspects of the drugs situation in communities, such as drug-dealing 
and drug-related crime and intimidation, requires a collaborative effort, across a range of 
agencies and sectors of society.  It was acknowledged that projects such as DRIVE (Drug 
Intimidation & Violence Engagement) are working well in addressing the issue of drug related 
intimidation and violence in many DATF communities.  However, further focus is required to 




Criminal activity and an active illicit drug market can create an intimidating and frightening 
environment in an affected community. The concentration of illicit drug markets in particular 
areas means that already marginalised communities must also deal with social and public 
disorder and property crime associated with the sale and distribution of drugs. The use of 
violence or the threat of violence to enforce debts further impacts on these communities by 
creating an atmosphere of fear and undermining the health and wellbeing of families affected 
and the wider community. 
 
Performance measurement 
Reducing Harm, Supporting Recovery set out to provide a way of measuring the collective 
response to the drug problem, through a performance measurement framework. The strategy 
committed to the development of a performance measurement system to incorporate a resource 
allocation model (RAM) to enable funding to be allocated on a more equitable and rational 
basis which takes account of underlying need in DATF areas and targets those communities 
which face a higher risk of substance misuse.  It was intended that over time the RAM will take 
account of the totality of public funding at the disposal of the DATF partners. As information 
systems improve in the coming years, the performance measurement system could draw upon 
more data sources to develop a more precise measure of problem substance use. 
 
It was noted during the engagement with stakeholder that there was an urgent need to progress 
the action on the Performance Measurement System through an inclusive process in partnership 
with task forces, voluntary and community sectors.  It was felt that the Trutz Haase 
measurement system needed to be progressed to identify and target those areas of greatest 
disadvantage combined with substance misuse.  
 
In addition, there was a call for a common system to evaluate the outcomes of services. This 
needs to combine quantitative methods with rigorous qualitative approaches, and at least some 
of the latter should consist of participatory research.  Without agreed indicators of success, 
there cannot be agreement between all the relevant parties - service users, affected families, 
communities, statutory, community and voluntary organisations - on which services and 
approaches are working and which are not.  Therefore, the national structures of the strategy 
should drive the development of a common system.  It was proposed that a common evaluation 
system, to be used in each Task Force area/region, should include mechanisms for assessing: 
- overall levels of drug/alcohol use in the area 
 
 
- local awareness of, and attitudes to, substance misuse 
- the overall harm caused locally by substance misuse 
- the quality of life of service users and other members of the community 
- the long-term impacts of services on individuals 




Research is considered vital to provide an accurate picture of substance use/misuse within 
communities and in drug markets and trends.  Without evidence, it is hard to make a convincing 
case for change and also to provide an appropriate service response.  However, there were 
challenges in providing timely and appropriate responses to drug trends.  The markets and 
drugs are continuously evolving.  
 
To provide an accurate picture/ reflection of substance misuse, current trends and impact of 
substance use/misuse on the individual and the community, a strong focus on communities of 
interest is required.  Stakeholder feedback indicated that RHSR needs a stronger focus on 
research going forward, especially for 
o the LGBTI community, 
o Travellers and Roma, and 
o Older service users.  
 
This research could provide an accurate picture of substance use/misuse within these 
communities which could then be used to provide best practice support to service users and 
trainings to organisations/services supporting the separate groups. 
 
The issue of focussing on “addiction” and “recovery and rehabilitation” rather than particular 
drugs of choice was raised.  This focus might inform change to service provision, but where 
resources are limited, it could provide a focus on areas of need. 
 
It was felt that the research focus of the strategy has been lost.  The benefits of the wider input 
and consultation done under the NACDA was recalled and it was suggested that the research 
agenda could be informed by a wider group, not restricted to the HRB.  It was further suggested 
 
 
that research expertise has been diluted in the current structures, which could be addressed by 
the establishment of a specific structure focused on the issues of data collection and research 
reporting directly to the National Oversight Committee. 
 
Diversity and inclusion  
The strategy recognises the diversity evident among drug users and the steps required in 
providing services that can accommodate this diversity and address the needs of particular 
groups in relation to problem drug and alcohol use.  
 
The issue of gender and the specific needs of women were raised by stakeholders.  The current 
strategy’s gender focus has tended to be mostly in the area of pregnancy and motherhood, 
which is in line with many other jurisdictions.   Going forward actions could be considered that 
are gender specific, gender sensitive and gender transformative.  
 
Overall, it was felt that although there are some really good initiatives in RHSR which target 
individual groups, further consideration needs to be given to the intersectionality and varying 
needs of specific groups and that services needs to be tailored to suit the needs of the individual.  
Some of the groups mentioned include: LGBTI, Travellers & Roma, ethnic minorities, under 
18s and young people, women, people who are homeless. 
 
Stigma 
The issue of stigma, and the stigmatisation of people in addiction and their families, was raised 
by several stakeholders.  Stigma can have a detrimental effect on the mental and physical health 
and wellbeing of people who use drugs, and also on those with alcohol dependency, which can 
act as a barrier to seeking help and treatment.    
 
This issue has been included on the drugs policy agenda at both international and EU level. 
The EU Drugs Strategy 2021-2025 specifically mentions the reduction of stigma as a priority 
area along with the inclusion of people who have been stigmatised in the development of 
policy.    
 
Stakeholders outlined a need for the strategy to challenge and address drug-related stigma.  A 
pilot anti-stigma training programme developed and launched by Citywide and SAOL in 
partnership with IHREC and Trinity College Dublin under the Stop the Stigma Campaign was 
 
 
mentioned as a good example of anti-stigma training.  This pilot is being evaluated at present, 
but a number of stakeholders called for the roll-out of anti-stigma training nationally building 
on the findings of the evaluation being carried out by Trinity College.   
 
Stakeholders also highlighted that some people in addiction can suffer a greater degree of 
stigmatisation, for example, women in addiction and in particular mothers.  Women and in 
particular mothers who use drugs and alcohol can be disproportionately affected by their 
addiction and the associated stigma.  Gender specific and tailored initiatives and treatment 
pathways are required so that they have the confidence to ask for support and feel worthy of 
treatment.    
 
National oversight structures for the Strategy 
Reducing Harm Supporting Recovery is a cross-cutting area of policy involving the collective 
input of the statutory, community and voluntary sectors, to provide a coordinated response to 
counter the issue of problem drug and alcohol use in our society.  National oversight and 
coordination structures play an important role in supporting the effective implementation of 
the different national drugs strategies. These structures have also helped to facilitate multi-
agency working, and tackle blockages to implementation which can result in barriers for those 
who wish to access substance misuse services. 
 
Feedback received during the review of the strategy indicates that the structures are very 
efficient in terms of identifying lead agencies and accountability and having clearly defined 
roles and responsibilities for all members to contribute toward the development and reporting 
on each action.  However, it was felt that areas of the structures are not working as well as 
intended.  Many reported a duplication in membership of the structures, insufficient attendance 
and participation as well as insufficient opportunities for focussed discussion on a broad range 
of topics covered by the strategy.  Others referred to discussions being centred only on health 
and justice items. 
 






(iii) Focused policy assessment of expenditure and performance under the national 
drugs strategy 
 
Focussed policy assessment 
A focussed policy assessment (FPA) of expenditure and performance was commissioned by 
the Dept of Health and carried out by the Irish Government Economic and Evaluation Service 
(IGEES).  The demand for treatment services continues to grow as drug use becomes more 
prevalent in society following the economic recovery.   
 
Having an estimate of the total economic burden that problem drug and alcohol use places on 
society, both in terms of the labelled expenditure on initiatives to ameliorate this problem, as 
well as the costs of dealing with the consequences of it, is a first step in generating the economic 
evidence base with which to evaluate public policy on substance misuse.  
 
The aim of the FPA was to review the rationale, efficiency, and effectiveness of treatment 
programmes.  The FPA has the following components:  
• Outline the background to the strategy and its objectives; 
• Profile labelled (programme) expenditure, in line with the current EU requirement for 
public expenditure estimates and best-practice guidelines provided EMCDDA;  
• Estimate unlabelled expenditure on drugs and alcohol and productivity costs 
• Examine strategy performance in terms of inputs and outputs; 
• Consider the continued relevance of expenditure programmes in terms of alignment 




• The examination of labelled and unlabelled expenditure, and lost productivity costs 
included here, gives an indication of the scope of the economic costs of drug and alcohol 
misuse in Ireland.  
Labelled Expenditure  
• Labelled expenditure refers to planned spending targeted at drug or alcohol issues (e.g 
treatment of addiction), usually reported as such in public accounts. Data on labelled 
expenditure is collected annually by the Department of Health and provided to the HRB 
 
 
as part of their role within the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Limitations in this dataset point to the need for improved data 
collection for the next stage of RHSR.  
• Although complete and consistent annual reporting from all reporting bodies has not 
yet been achieved, it is estimated that labelled expenditure on drug and alcohol misuse 
in Ireland exceeds €200 million per year.  
• HSE Addiction Services accounted for over €100 million of labelled expenditure in 
2019, with average year-on-year increases of 4% since 2014.  
Unlabelled Expenditure & Productivity Costs  
•  Unlabelled expenditure refers to unplanned drug and alcohol related spending that is 
not explicitly categorised as such in public accounts (e.g. imprisonment for drug-related 
crime), making it more difficult to disaggregate and quantify.  
• Productivity costs capture the indirect cost of lost production resulting from 
imprisonment, morbidity and premature death, which is an important component of the 
economic burden of drug and alcohol misuse from a societal perspective.  
• Previous estimates of the societal cost of problem alcohol use have produced estimates 
ranging from €2.4 to €3.7 billion per year, with annual healthcare costs alone having 
been estimated at between €0.8 and €1.5 billion.  
• This paper is the first to estimate unlabelled expenditure on problem drug use, finding 
that approximately €87 million is spent annually within hospitals, prisons, and the 
criminal justice system in dealing with the medical and legal consequences of drug use. 
Productivity losses associated with drug use are estimated to be in the region of €61 
million per annum.  
• Calculation of cross-sectional, annual costs fails to capture the longer-term financial 
implications of multi-year prison sentences or future productivity losses due to 
premature mortality. When a longitudinal approach is used to assess the net present 
value of current and future unlabelled expenditure and productivity costs due to drug 
misuse, the combined estimate rises to over €650 million.  
Performance of Reducing Harm, Supporting Recovery  
• The strategy includes 5 goals which are broken down into objectives, strategic actions 
and performance indicators. In total there are 50 strategic actions and 29 performance 
indicators. Data for 12 of the 29 performance indicators were available and sourced for 
 
 
a trend analysis, these are reported in Section 4. The performance of RHSR is analysed 
based on available data from the performance indicators listed under each of the 5 goals:  
1. Promote and protect health and wellbeing  
2. Minimise the harms caused by the use and misuse of substances and promote 
rehabilitation and recovery  
3. Address the harms of drug markets and reduce access to drugs for harmful use  
4. Support participation of individuals, families and communities  
5. Develop sound and comprehensive evidence-informed policies and actions  
•  Limitations in the availability of data has constrained the conclusions that can be 
drawn on the progress made under each goal. It is clear that some indicators are 
moving in the right direction (for example rates of alcohol use among 10-17 year olds 
are reducing), some are moving in the wrong direction (for example increases in non-
uptake of treatment among vulnerable groups) and for some it is difficult to determine 
(for example, increases in numbers in receipt of certain services could be positive if 
demand is being met but could also indicate increased prevalence of harmful drug 
use).  
•  This paper has also highlighted the importance of understanding demand and unmet 
need for treatment services as it contextualises whether these services are meeting 
population needs and therefore whether the strategy is achieving its objectives.  
•  An assessment of the status and availability of each of the 29 performance indicators 
was produced as part of the analysis which will inform the mid-term review of the 
strategy. A summary of this assessment is included in Appendix 1. Improvements in 
data availability and quality will support the ongoing monitoring of RHSR out to 2025 
and any future evaluations in this area.  
Conclusions 
•  The available evidence base on the costs of drug and alcohol misuse is typically 
limited by data availability and is estimated using varied methodological approaches. 
Opportunities exist to improve reporting of labelled expenditure across Government 
Departments, and consensus is needed on what the optimal approach is to estimating 
the direct and indirect costs of drug and alcohol misuse.  
• Notwithstanding these limitations, our findings indicate that unlabelled expenditure 
and productivity costs contribute significantly to the overall economic burden of 
problem drug and 7 alcohol use. Therefore they are an important component 
 
 
(alongside labelled expenditure) of any examination of the value of policies to address 
drug and alcohol misuse which relates changes in inputs (planned programmes to 
tackle these issues) to changes in outputs and costs.  
• The performance of Reducing Harm Supporting Recovery has been examined in terms 
of available data on the performance indicators under the five goals of the strategy. 
However, limitations in the availability and quality of data has constrained the 
conclusions that can be drawn. For some performance indicators, data will become 
available as time goes on, while others will need to be revised to be able to more 
accurately reflect the performance of goals in the strategy and to ensure their 
usefulness in future evaluations.  
• It was not possible to break down labelled expenditure by the proportion which was 
directed towards a health-led response to drug and alcohol misuse (e.g. expenditure 
on prevention) and that which relates to a criminal led response (e.g. expenditure on 
incarceration). It was similarly not possible to break down expenditure by that part 
which principally served each goal listed in the strategy. As such, an assessment of 
what was achieved for such expenditure was not possible in this FPA. Addressing the 
limitations of datasets and the performance indicators identified in this FPA are 
necessary steps for improved monitoring and future evaluation of RHSR and public 
expenditure on drug and alcohol programmes more generally.  
• Improved ability to evaluate public expenditure would ensure that the health and 
wellbeing of individuals, their families and communities are best served by public 
policies that address the harms associated with drug and alcohol misuse. 
 
The full report is available at https://www.gov.ie/en/collection/8930f-spending-review-2021/ 




(iv) Drug prevalence trends and performance indicators  
 
Drug prevalence trends 
The National Drug and Alcohol Survey (NDAS) provides information on alcohol and tobacco 
consumption, and drug use among the general population in Ireland.  The extent and pattern of 
drug use in the general population is one of the five key indicators developed by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and adopted by EU Member 
States.  NDAS also surveys people’s attitudes and perceptions relating to tobacco, alcohol and 
other drug use and records the impact of drug use on people’s communities. The survey report 
can be found here. 1  
 
Use of any illegal drug 
The survey found that 27% of people aged 15–64 in Ireland reported use of an illegal drug 
(cannabis, ecstasy, cocaine powder, magic mushrooms, amphetamines, poppers, LSD, new 
psychoactive substances (NPS), solvents, crack, and heroin), at some time in their lives, 9% 
had used an illegal drug in the last year, recent use, and nearly 5% in the last month.  Although 
prevalence of recent use was similar to that in the two preceding surveys, there was increase in 
the use of cocaine, ecstasy, LSD, amphetamines and poppers and a slight decrease in the use 
of cannabis. 
 
Males were more than twice as likely as females to report recent use of an illegal drug, except 
in the youngest age group (15-24) which had little difference between males and females. This 
was the group that had the highest prevalence of illegal drug use, with the exception of cocaine 
and new psychoactive substances.  The cohort that reported the highest level of recent drug use 
was males aged 25–34 years, one in four whom had used an illegal drug in the last year. The 
median age at which people had first used the common illegal drugs had increased slightly 
compared to the 2002/03 survey. 
 
Those who reported recent illegal drug use were more likely to report use of at least two illegal 
drugs than was in the case in the 2014/15 survey.  The proportion of those reporting recent use 







Use of specific drugs 
While recent cannabis use among males overall decreased between 2014/15 and 2019/20, 
among males aged 25-34 use has continued to increase.  Of those who had used cannabis in the 
past year, nearly one in five met the criteria for cannabis use disorder (CUD), although there 
has been a noticeable decrease in CUD among males and 15-34-year-olds since the last survey. 
Ecstasy (MDMA) was the second most commonly used illegal drug in the year prior to the 
survey.  Recent ecstasy use has increased with the largest increase among males aged 25–34 
years, almost one in ten of whom had used it in the past year.  A similar proportion of this 
cohort had used cocaine in the past year, with males being many times more likely to report 
recent use than females.  Noticeable increases were also observed among females aged 15–24 
years.  Overall, recent cocaine use had increased significantly among males and to a lesser 
extent among females. Recent use of sedatives/tranquilisers decreased in 2019/20 and is 
currently at 2006/07 levels.  Less than one percent of respondents reported non-medical use of 
sedatives/tranquillisers in the last 12 months, and just under 2% reported non-medical use of 
opioid pain relievers. 
 
Factors associated with drug use 
Among the younger age cohort, the prevalence of recent drug use was higher among those who 
had only completed lower secondary school education compared to those with higher 
educational attainment or still in education.  Employment status or being a student was not a 
significant factor associated with recent drug use.   Respondents aged 15-34 who lived in 
Dublin had the highest prevalence of recent drug use. The most common reason respondents 
gave for not ever using drugs was ‘just not interested’. Young respondents were more likely to 
cite concerns around health problems and becoming addicted, while older respondents were 
more likely to cite no opportunity or illegal drugs available. 
 
Perceptions and attitudes 
Respondents were asked if they agreed with permitting cannabis for medical and recreational 
use. There was almost universal agreement for permitting cannabis for medical use. There was 
far less support for permitting cannabis for recreational use. Support was higher among 15-24-
year-olds and lowest among those aged 65 and over.  The majority of recent cannabis users 
agreed with permitting recreational cannabis use while a much small proportion of never users 
agreed.  The majority of respondents reported disapproval or strong disapproval for smoking 
cannabis, with a little over half perceiving ‘great risk’ to be associated with smoking cannabis 
 
 
regularly. The most common perception among respondents of people who had an addiction 
was ‘more as a patient’, with a small number responding ‘more as a criminal’. 
 
Impact on local communities 
Questions on the impact of drug use on local communities were included in the 2019/20 NDAS 
for the first time. More than one-third of respondents stated that there was a problem with 
people using or dealing drugs in their local area.  Those who reported that there was a very or 
fairly big problem with people using or dealing drugs in their local area were most likely to 
live in more deprived areas, with 44% of respondents in the most deprived quintile compared 
to 19% in the least deprived quintile.  One in ten respondents had either personal experience of 
drug-related intimidation or knew somebody who had been intimidated.  Those who had 
experience of drug-related intimidation were twice as likely to live in the most deprived quintile 
compared to less deprived quintiles. 
  
Outcome Indicators Framework 
The Department and the Health Research Board (HRB) are developing an outcomes framework 
for the National Drug Strategy. As a first step, the HRB has developed an indicator set to 
provide a structured approach to collect and report relevant and appropriate data which can be 
used to assess the impact of the strategy’s actions on the agreed aims of the strategy.  The 
selection of these indicators was informed by the EMCDDA epidemiological and drug supply 
indicators, the Healthy Ireland Outcomes Framework, the European Core Health Indicators, 
the World Health Organization’s Global Monitoring Framework for the Prevention and Control 






(v) Rapid Assessment of impact of COVID-19 on Drug and Alcohol services  
  
The Covid-19 pandemic had a stark risk for users and services alike. Due to the health 
implications of illicit drugs, people who use drugs are more susceptible to the negative effects 
of the virus, which means that the services they use and rely on were more important than ever 
before.  
 
The impact of COVID-19 on services is significant, and multi-faceted, their capacity to deliver 
services and what this means for service users greatly changed throughout he pandemic and at 
various levels of restrictions.  
 
The European Monitoring Centre for Drugs and Drug Addiction highlighted the emerging risks 
linked to the COVID-19 pandemic for people who use drugs and those providing services for 
them from a European perspective. They noted the need to assess these changes as to encourage 
planning, review and adaption of frontline and specialist drug interventions. 
 
Straight away and throughout the pandemic, services adapted greatly in how they operated in 
order to provide a service, while complying with restrictions. The Drugs Policy Unit of the 
Department of Health commenced an assessment of the impact of Covid-19 on drugs and drug 
services so we could get a picture of the challenges that have been brought to the country, and 
services. This included a literature review, data review, case studies, a national online survey 
and stakeholder engagement. It was conducted so we can better inform our policy and practice 
for the future, as this pandemic and its impact will be with us for a substantial time to come.  
 
The report on the Impact of COVID-19 on Drug and Alcohol Services and People who use 
Drugs highlighted the impact of the COVID-19 pandemic on service capacity, staff, operations, 
and governance and reporting. Services provided information on how they adapted to the 
challenges of COVID-19 by employing the likes of online or telephone communication 
methods and public health measures like PPE and physical distancing, as well as the challenges 
that remain such as the availability of support services, contingency planning for future 
outbreaks, implementing social distancing in their premises and the financial costs of new 
equipment. Survey findings have also provided an indication of the negative impacts the 




Stakeholder engagement on the impact of Covid-19 on drug and alcohol services 
As part of rapid assessment, a stakeholder engagement was held to consider the preliminary 
findings and the implications in November 2020. This allowed those working across the sector 
to engage with the findings and give further insight on the policy implications that arise from 
this research. The feedback is summarised below. 
 
How can drug and alcohol services be supported to adapt to COVID-19? 
• Clear guidance for each level of restrictions, specified for drug services.  
• Ensure community drug projects are recognised as essential services.  
• Staff support to deal with trauma, stress, low morale and redeployment.   
• Support for blended virtual approach, including IT structures, support for users, digital 
policy for the sector and staff training, all with the long-term in mind.  
• Increase in funding to deal with higher waiting lists, the provision of wrap-around 
services, COVID proofing the facilities and providing PPE and new IT structures.  
• Access to schools should be facilitated for the Tasktforces, as to assist in SPHE.  
• Maintain the changes in the provision of OST and ensure support for wrap-around 
care for this cohort.  
• Support for continuing the interagency working that had been seen throughout the 
pandemic.  
 
How can people who use drugs be empowered and supported during COVID-19? 
• Enactment of care planning and case management, for meaningful and person-centred 
wrap-around care.  
• Domestic abuse, mental health & child protection have been highlighted as areas that 
have been missed with remote working, more focus is required.   
• Tech & wifi should be provided to service users to ensure access.  
• Recognition of services as essential.  
• Development of peer-to-peer contact.  
• Home delivery of medication & methadone for those who are medically vulnerable.  
• Naloxone available over the counter.  
• Provision of harm reduction interventions  
• Service user feedback and participation.  
• Increase contact with underrepresented groups.  
 
 
• Promote role of An Garda Síochána in care provision and signposting - 24 hours a day 
• School wellbeing platforms.  
 
The results of the assessment were presented to the National Oversight Committee in December 
2021.  This presentation concluded that COVID-19 brought higher risks and service disruption, 
including challenges in restoring services. The research provided an insight into the impact, 
innovative practice responses, challenges and the new partnerships and collaborations that have 
arisen on the ground. Key needs identified were the framework for restoration of drug & 





(vi) International context: the European Union Drugs Strategy 2021-2025 and the 
British-Irish work sector on drugs and alcohol.  
 
The EU Drugs 2021-2025 sets out the political framework and priorities for EU drug policy in 
the period 2021-2025. This approved document has reaffirmed the strong, evidence-based, 
comprehensive, and balanced approach to drugs, that has been seen previously in the EU, with 
the preservation of human rights at its core. 
 
Strengthening the connections with European drugs policy is important, as Ireland cannot 
address the drugs issue in isolation from European colleagues. At EU level, Ireland has 
advocated for mechanisms to promote synergies between the European and our national 
strategies. This includes opportunities to share learning and good practice between Member 
States, which will also be supported in the National Drugs Strategy.  
 
The EU Drugs strategy includes a new, dedicated chapter on addressing drug related harms, so 
as to prevent or reduce the health and social risks for drug users. This includes measures to 
reduce the incidence of drug-related infectious diseases, to prevent overdoses and drug-related 
deaths and to provide alternatives to coercive sanctions. The strengthening of policy in this 
area mirrors our national strategy and will help to influence, shape and progress our own 
initiatives in these areas, such as the Health Diversion Programme and the Supervised Injection 
Facility.  
 
Ireland chairs the British-Irish Council work sector on drugs and alcohol. This provides a forum 
for cooperation on drug and alcohol responses among the eight administrations in Britain and 
Ireland. By working together, member administrations can share learning on evidence-based 
policies, services and interventions to reduce drug and alcohol harms. The forward work plan 
identifies five policy initiatives to address the harms of drugs and alcohol use over the next 
three years. These include the delivery of drug and alcohol services during COVID-19, the 
reduction of drug related deaths, financial mechanisms to reduce alcohol-related harms, joined 
up approaches to meeting the health and social needs of people who are homeless and in 





(vii) Strategic priorities for 2021-2025 
 
Strategic priorities for implementing the national drugs strategy 2021-2025  
Six strategic priorities are identified to strengthen the implementation of the national drugs 
strategy for the period 2021-2025. The strategic priorities reflect the lessons and the 
stakeholder feedback from the mid-term review and capture the commitments in the 
Programme for Government. The Rapid Expert Review also recommended having a few key 
priorities (with specific objectives, related actions and appropriate performance indicators), in 
order to provide greater coherence in the strategy and facilitate cross-pillar and cross-
government coordination. 
 
The strategic priorities reflect stakeholder feedback that the diversity evident among people 
who use drugs should be recognised and steps should be taken to provide services that can 
address this diversity and reflect the needs of different groups in relation to problem drug use. 
Stakeholders also want a stronger alignment of policies, strengthened governance structures 
and a continuation of the collaborative arrangements developed in response to COVID-19. 
 
The strategic priorities are designed to reinforce the health led-approach to drug and alcohol 
use. In particular, they are connected with the Sláintecare Implementation Strategy and Action 
Plan 2021-2023 and the Healthy Ireland Strategic Action Plan 2021-2025. The priorities also 
align with relevant priorities in the EU Drugs Strategy and UN policies on drugs, children and 
sustainable development.  
 
Specific actions will be associated with each of the priorities, including actions that are still 
relevant from the strategic action plan 2017-2020, and new actions required to deliver the 
priorities. It is expected that each priority will have between 4 and 6 actions. An indicative list 
of actions will be identified for each priority and agreed with the relevant stakeholders. Not all 
continuing actions will be associated with a strategic priority; for example, most of the actions 
pertaining to goal 3 - reducing the supply of drugs – will continue to be reported upon by the 







The six priorities are: 
1. Strengthen the prevention of drug and alcohol use and the associated harms among children 
and young people; 
2. Enhance access to and delivery of drug and alcohol services in the community; 
3. Develop integrated care pathways for high-risk drug users to achieve better health 
outcomes; 
4. Address the social determinants and consequences of drug use in disadvantaged 
communities; 
5. Promote alternatives to coercive sanctions for drug-related offences; 
6. Strengthen evidence-informed and outcomes-focused practice, services, policies and 
strategy implementation. 
 
The spreadsheet attached at appendix 3 presents (in summary form) the strategic priorities, the 
relevant RHSR goals, alignment with other policies, commitments in the Programme for 
Government, proposed outcome indicators and lead partners.   
 
The first priority focuses on protecting children and young people from drug use and the 
associated harms. It is aligned with Article 33 of the UN Convention on the Rights of the Child:  
To take all appropriate measures, including legislative, administrative, social and 
educational measures, to protect children from the illicit use of narcotic drugs and 
psychotropic substances and to prevent the use of children in the illicit production 
and trafficking of such substances. 
This priority will protect children and young people across a variety of school, community and 
family settings by increasing resilience and strengthening life skills and healthy life choices. It 
will be informed by the European Prevention Curriculum and the International Standards on 
Drug Use Prevention. 
 
The second priority is to enhance community care for people who use drugs by providing 
health and social care services at the community level to meet identified health needs. This will 
be supported though the development of a drug services care plan formulated on the basis of 
the new six health regions agreed by Government in 2019. Particular focus will be put on 
ensuring access to services for women, people in rural areas, ethnic minorities and the LGBTI+ 
community. This priority will consider models of care for people who use drugs and have co-
morbidities. It will also address the stigma linked to drug use and drug addiction and its impact 
 
 
on access and delivery of health services. This priority meets target 3.5 in the UN Sustainable 
Development Goals: strengthen the prevention and treatment of substance abuse, including 
narcotic drug abuse and harmful use of alcohol. 
 
The third priority is to develop integrated care pathways for high-risk drug users, including 
people who are homeless, offenders, stimulant users and people who inject drugs, so as to 
achieve better health outcomes. These high-risk drug users have complex health and social care 
needs that make them vulnerable to drug overdose and pre-mature death. Integrated care 
pathways are required to deliver the best outcomes for this cohort, that connect care settings 
between GPs, primary/community care providers, community specialist teams and hospital-
based specialists. The experience of the Dublin COVID-19 homeless response provides a 
template for integrated care. A key outcome indicator will be the reduction in drug deaths. 
Strengthening harm reduction responses to high-risk drug use associated with the night-time 
economy and music festivals, including proposals for drug monitoring, will form part of this 
priority. 
 
The fourth priority recognises the additional challenges arising from drug use in 
disadvantaged communities, including the Traveller community. This priority will address the 
underlying social and economic determinants that increase the prevalence of problematic drug 
and alcohol use in certain communities. It will also tackle the criminality and anti-social 
behaviour associated with the drug trade that imposes a heavy burden on poor communities. 
These issues require action across government to promote community development and 
community safety. Ensuring synergy with the Sláintecare Healthy Communities programme to 
address health inequalities will be a key objective.  
 
The fifth priority is to reinforce the health-led, rather than criminal justice-led, approach to 
people who use of drugs and who commit drug-related crimes, such as robbery. The main focus 
will be on the rollout of the Government health diversion programme for people in possession 
of drugs for personal use, which will offer compassion not punishment. Other initiatives, such 
as the drug treatment courts, will also be supported. A particular emphasis will be on the 
exchange of best practice on alternatives to coercive sanctions with EU member states.  
 
Finally, the sixth priority is to strengthen the performance of the strategy though promoting 
evidence-based and outcomes-focused practices, services, policies and strategy 
 
 
implementation. Learning the lessons of the response to COVID-19 will be a key theme. This 
priority will also strengthen Ireland’s contribution to best practice at the EU level, in 
collaboration with the EMCDDA and the HRB Reitox national focal point. It will also identify 
service innovation from the network of drug and alcohol task forces, especially under the three-
year strategic initiatives.  
 
Supporting these strategic priorities will be a number of horizontal themes: 
- involvement of service users in the design and delivery of services based on a human 
rights perspective and the promotion of health literacy 
- active and meaningful participation of civil society in the development, implementation 
and evaluation of policies and services 
- good governance, accountability and mutual respect by all partners  
- cross-sectoral funding and the targeting of additional resources 
- Public Sector Equality and Human Rights Duty 
 
The strategic priorities will be delivered through specific actions and progress will measured 
though outcome indicators. An agreed list of actions and indicators will be developed for each 
priority.  
 
Strategic implementation groups will be established to support the delivery of the strategic 
priorities and to reinforce cross-agency collaboration, a key value of the strategy. The SIGs 
will be action-oriented and comprise stakeholders involved in delivery of the relevant actions. 
The SIGs will be chaired independently and the chairs will report on the delivery of their 
actions to the national oversight committee and will be a member of the committee. A service 
user and a civil society nominee will be a member of each SIG, as will a nominee of the network 
of task forces.   
 
There will be two sub-committees of the NOC – an Early Warning and Emerging Trends sub-
committee and a Research sub-committee. The latter will oversee the research outputs of the 
strategy, including the national drug and alcohol survey, in conjunction with the Health 
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The national drug strategy, Reducing Harm, Supporting Recovery – a health-led response to 
drug and alcohol use in Ireland 2017-2025, sets out government policy on drug and alcohol 
use until 2025.  The strategy outlines an integrated health-led approach to drug and alcohol use, 
focused on reducing the harms for individuals, families and communities and based on 
providing person-centred services promoting rehabilitation and recovery.   
 
The vision of the strategy is for   
A healthier and safer Ireland, where public health and safety is protected and the harms 
caused to individuals, families and communities by substance misuse are reduced and 
every person affected by substance use is empowered to improve their health and 
wellbeing and quality of life.   
 
The strategy is structured around five strategic goals.  The 50 actions to support these goals are 
outlined in the Action Plan and are to be delivered over the period 2017-2020.  The 
implementation of these actions is monitored though the national oversight structures, 
supported by the coordinated system of monitoring, research and evaluation set out in the 
strategy.  This progress report has been prepared by the lead agencies and reports on the 
implementation of the actions to the end of 2020.  This report also reports on the status of the 
actions, across 5 settings: 
Black –  
action not yet 
scheduled to 
start 
Green –  
action broadly 
on track 
Amber –  
action 
progressing but 
with a minor 
delivery issue 









The table below gives an overview of the progress to the end of 2020 on implementation of 
the 50 actions contained in Reducing Harm Supporting Recovery.   
Strategic Goals Black Green Amber Red Blue 
Goal One:  
Promote and Protect Health and 
Wellbeing   
2 3 2 4 
Goal Two:   
Minimise the harms caused by the 
use and misuse of substances and 
promote rehabilitation and 
recovery   
6 5 3 3 
Goal Three:  
Address the harms of drug 
markets and reduce access to 
drugs for harmful use.  




Goal Four:  
Support participation of 






Goal Five:  
Develop sound and 
comprehensive evidence-









Total            14 12 8 11 
 
This indicates that 25 actions have been delivered, either completely or broadly on track.  A 




Goal One: Promote and Protect Health and Wellbeing 
RHSR Strategic 









1.1.1                                                                            
Ensure that the 
commitment to an 
integrated public 
health approach to 
drugs and alcohol is 
delivered as a key 
priority 
 
1.1.1 (a)                                     
Develop an initiative to 
ensure that the 
commitment to an 
integrated public health 
approach to drugs and 
alcohol is delivered as a 
key priority                     
DOH 
A prevention and education initiative encompassing 1.1 was under 
development.    Funding for this initiative was reallocated for the 
restoration of drug and alcohol services, in the context of Covid-19 in 
2020.          




1.1.1 (b)                                           




action on alcohol  
                                  
DOH 
Review approaches to prevention and education, building on best 
practice.  The HSE funds the Alcohol Forum to support community 
mobilisation on alcohol.   
1.1.2                                                                         
Improve the delivery 
of substance use 
education across all 
sectors, including 
1.1.2 (a)                                            
Organise a yearly 
national forum on 
evidence-based and 
effective practice on 
HRB 
The planned National Drugs Forum was not held in 2020 due to 
COVID-19 restrictions.  The HRB are planning an online forum in 





services for people 
using substances and 
other relevant sectors. 
drug and alcohol 
education                                    
  
 
1.1.2(b)                                         
Develop a guidance 
document to ensure 
substance use education 
is delivered in 
accordance with quality 
standards. 
  
HRB Deferred following discussion with DoH 
1.2.3                                                                             
Support the SPHE 
programme. 





and Drug and Alcohol 
Task Forces given the 
importance placed on 
the continued building 




Following a number of meetings between the DoE and Regional DATF 
Coordinators network representatives on the National Oversight 
Committee for the Drugs Strategy, the Regional DATF Coordinator 
reps developed a discussion paper which was then discussed and 
agreed with LDATF Coordinators network. This was then used to 
inform a support guide for schools and parents with links to evidence 
informed and recognised resources and publications, signposting to 
area-based support along with DATFs and contact details. This was 
developed in 2020 and is currently being finalised.   
It will be circulated to schools in 2021, as soon as it is possible to do so 
when there is a resumption of ‘normal services’ - including the issue of 





1.2.3 (b)                                           
Ensure that all SPHE 
teachers, guidance 
counsellors and Home 
School Community 
Liaison co-ordinators 




Resources to support the Junior Cycle short course on SPHE were 
developed by the HSE in consultation with the NCCA and the DES.   
 
Work continues on supporting schools as they embark on their 
Wellbeing Promotion Process.  This involves schools reviewing all 
aspects of their wellbeing promotion across the curriculum, culture and 
environment, policy and planning and relationships and partnerships.  
The PDST developed Continuing Professional Development (CPD) on 
wellbeing promotion which is due to be rolled out in face-to-face 
training in Sept 2021.  Meanwhile the PDST are developing online 
materials and webinars.                                                                                                                                
 
A comprehensive programme of CPD to support the SPHE programme 
was provided by DES teacher support services to newly qualified and 
serving teachers at primary and post-primary. Due to the COVID-19 
pandemic, the delivery of CPD moved online during 2020. This did not 
affect the level of CPD provided for teachers as they continued to 
access regular CPD events and the level of CPD provided was similar 
to 2019. 
 
The CPD directory of opportunities relevant to wellbeing (including 
SPHE) has been updated for the 2020/21 school year and can be found 
on the following page: 
https://www.gov.ie/en/publication/af24b-wellbeing-guidance-
documents-for-parents-students-and-schools/#school-staff-primary-
schools          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       




1.2.4 Promote a health 
promotion approach to 
addressing substance 
misuse. 
1.2.4(a)                                             
In line with the Action 
Plan for Education, 
commence and roll out 
a national programme 
to support the 
implementation of the 
Wellbeing Guidelines 
to all primary and post-
primary school 
DES 
The wellbeing guidelines are replaced by the Wellbeing Policy and 
Framework for Practice.   Work continues on supporting schools as 
they embark on their Wellbeing Promotion Process which is outlined 
in the Wellbeing Policy and Framework for Practice.  This involves 
schools reviewing all aspects of their wellbeing promotion across the 
curriculum, culture and environment, policy and planning and 
relationships and partnerships.    
The Wellbeing Policy sets outs standards for wellbeing practices 
across the Continuum of Support at the whole school preventative level 
(Support for All) and also at the targeted and more individualised 
levels (Support for Some and Few). Further work is required on the 
process for use in all centres of education. An Action Research Project 
concluded in 2020 which is informing the development of wellbeing 
CPD for schools.                                                            
In view of the various challenges facing schools on resumption in 
September 2020, schools are being given the option to defer the 
increase of wellbeing provision at Junior Cycle from 300 to 400 hours 




1.2.4(b)                                             
In line with the Action 
Plan for Education, 
develop Wellbeing 
Guidelines for Centres 





Further engagement on this required and some of the centres for 
example Youthreach etc are now part of the new Higher Education 






1.2.5   Improve 
supports for young 
people at risk of early 
substance use. 
 
1.2.5(a)                                          
Provide a continuum of 
support including a 
Student Support Plan as 
appropriate, for young 





The DEIS Plan 2017 continued to be implemented in 2020, as set out 
under action 1.2.5(a) above, to support students at greatest risk of 
educational disadvantage including early school leaving. This included 
the range of additional measures provided in response to the impact of 
Covid-19 including the summer education programme in 890 DEIS 
schools aimed to help students renew relationships, routines and 
connections with school and with learning ahead of the re-opening of 




1.2.5(b)                                         
Provide access to 
timely appropriate 












NEPS continued to provide its school-based psychological service to 
all primary and post primary schools through the application of 
psychological theory and practice to support the wellbeing, academic, 
social and emotional development of all learners.  
 
During school closures NEPS psychologists continued to provide a 
service to schools via remote access.   NEPS service includes a 
casework service to schools through the assigned NEPS psychologist. 
Psychologists provide consultation in relation to appropriate 
therapeutic interventions to be delivered in the school setting and 
engage in direct work with individual students as appropriate.  
 
In 2020 due to Covid19 some elements of casework service was 
modified to ensure compliance with public health and schools’ safety 
measures. As is normally the case, in the event that the need for a more 
 
 
targeted counselling or a specialised intervention was identified by the 
NEPS psychologist, a referral was made to an outside agency for 
evaluation and ongoing support.  In addition to casework NEPS 
psychologists worked with teachers to build their capacity by offering 
training and guidance for teachers. 
 
1.2.5(c)                                      
Implement School 
Attendance Strategies 






1.2.5(d)                                        
Prioritise initiatives 
under the new DEIS 
programme to address 
early school leaving 
DES  
The DEIS Plan 2017 continued to be implemented in 2020, as set out 
under action 1.2.5(a) above, to support students at greatest risk of 
educational disadvantage including early school leaving. This included 
the range of additional measures provided in response to the impact of 
Covid-19 including the summer education programme in 890 DEIS 
schools aimed to help students renew relationships, routines and 
connections with school and with learning ahead of the re-opening of 
schools in September and help to support ongoing social development 
and wellbeing 
  






The COVID-19 restrictions had an impact on the delivery of activities 
in 2020. However, LDCs were able to continue to provide supports and 
to offer some services online/by phone. Many activities in 2020 were 
continued from 2019 and included: 
o wellbeing and resilience programmes, 





awareness of drugs 
programme and youth 
work in collaboration 
with schools and other 
youth 
programmes/scheme 
o supporting men’s sheds and women’s groups, 
o suicide awareness and prevention initiatives, 
o supports to LGBT community, 
o developmental youth work, 
o empowering communities to address health and wellbeing 
issues, 
o child and family supports, 
o raising awareness of mental health issues, and 
o friendly call service.                                           
1.2.6                                 
Ensure those who do 
not seem to thrive in a 
traditional academic 
setting complete their 
education. 
Review Senior Cycle 
programmes and 
Vocational Pathways in 
senior cycle with a 
view to recommending 
areas for development. 
DES 
 
Arising from the impact of Covid on schools and the delivery of the 
examinations, the focus for the Department (and still remains) was the 
continuation of education and the safe planning and delivery of the 
Leaving Certificate examination.                                                                
The NCCA is now finalising its advisory report for the Minister for 
Education and the Department. The report is expected to be received 
early in 2021. The advisory report will look at priority areas, longer-
term goals and a proposed timeline and advice on the pace and scale of 
developments in senior cycle. Areas for development will include 
senior cycle programmes and pathways, curriculum specifications and 
assessment.                                                                                                                                                                                                                                                                                     
As set out in Action 1.2.5(a) the DEIS Programme continued to 
support those most at risk of educational disadvantage to experience 





1.2.7                               
Facilitate increased 
use of school 
buildings, where 
feasible, for 
afterschool care and 
out of hours use to 
support local 
communities. 
Engage with property 
owners and school 
authorities to facilitate 
increased use of school 
buildings, where 
feasible, for afterschool 
care and out of hours 





1.2.8                                   
Improve services for 
young people at risk 





Develop a new scheme 
to provide targeted, 
appropriate and 
effective services for 
young people at risk of 
substance misuse, 








1.3.9          Mitigate 
the risk and reduce the 
impact of parental 
substance misuse on 
babies and young 
children 
1.3.9(a)   
Develop and adopt 
evidence-based family 
and parenting skills 
programmes for 
services engaging with 
high risk families 
impacted by 
HSE, TUSLA 
(Joint lead)  
Reference activity for 2020 in action 2.1.17 Further strengthen services 








Build awareness of the 
hidden harm of parental 
substance misuse with 




(Joint lead)  
Training development completed end July 2020. However, pilot 
implementation delayed to 2021 due to COVID 19 restrictions.  
Hidden harm e-learning programme available on HSELand and 






services and children’s 
health and social care 
services that will 
facilitate a coordinated 
response to the needs of 





(Joint lead)  
Children First guidance and legislation 2017 underpins Hidden Harm 
training and interagency cooperation and places a number of statutory 
obligations on specific groups of professionals and on particular 
organisations providing services to children.                              
 
Training development completed end July 2020. However, pilot 
implementation delayed to 2021 due to COVID 19 restrictions 
 
1.3.9(d)  
Ensure adult substance 
use services identify 
clients who have 
dependent children and 
contribute actively to 
meeting their needs 
HSE, TUSLA 
(Joint lead)  
A process has been identified to identify clients with dependent 
children, using the NDTRS.  Training development will be completed 
end July 2020. However, pilot implementation delayed due to COVID. 
 
 
either directly or 
through referral to or 
liaison with other 
appropriate services, 
including those in the 
non-statutory sector 
1.3.10                                                                        
Strengthen the life-
skills of young people 
leaving care in order 
to reduce their risk of 
developing substance 
use problems 
Consider how best to 
provide necessary 
once-off supports for
Care Leavers to gain 
practical life-long skills 
in line with Action 69 
of the Ryan Report in 
order to reduce their 






1.3.11                                                                       
Strengthen early harm 
reduction responses to 
current and emerging 
trends and patterns of 
drug use. 
Establishing a working 
group to examine the 
evidence in relation to 
early harm reduction 
responses, such as drug 
testing, amnesty bins 
and media campaigns, 
to current and emerging 
trends including the use 
of new psychoactive 
substances and image 
HSE  
Working group established.   Working group report, highlighting 
international evidence, best practice and key recommendations based 
on the group’s evidence review, is under review at present and aim for 
publication in Q2 2021.     
Market research in relation to drug use in the night-time economy is 
completed.  Market research into young people’s knowledge and 
attitudes towards cannabis and cannabis related messages currently 
underway with cohorts under and over the age of 18 years old.   
Content developed with USI on club drug use and overdose, and new 





enhancing drugs and 
other high risk 
behaviours, including 
chemsex. 
to the development of the EMCDDA survey due for launch in 2021 
which will aim to capture use among those not presenting to traditional 
addiction services over the last 12 month.  TCD report on the findings 
of the 2019 festival drug use survey completed and awaiting 
publication.  Completed review of evidence from other countries and 
consider the possibility of conducting a pooled urine or wastewater 
study to improve knowledge on trends if feasible, and wastewater 
epidemiology is being reviewed to assist in identifying peaks in use 
patterns.  As regards harm reduction, new benzodiazepine awareness 
information, 3 advisory notices issued by the national clinical lead on 
new benzodiazepines, new naloxone content added to drugs.ie as well 
as the development of a number of COVID-19 specific harm reduction 
resources.  Club Drug Clinic continues to operate in the NDTC after 
brief closure due to Covid-19. 
 
 
Goal Two:  Minimise the harms caused by the use and misuse of substances and promote rehabilitation and recovery. 
RHSR Strategic 









2.1.12   
Strengthen the 




2.1.12 (a)    
Develop a 
competency 
framework on key 
working, care 
planning and case 
management                     
HSE 
The Competency Framework for Addiction Services and Homeless Services 
has been completed. The final consultation took place and amendments were 
made accordingly however, COVID priorities have delayed the publication 
Green 
  
2.1.12 (b)      
Extend the training 
programme on the 
key processes of 
the National Drugs 
Rehabilitation 
Framework         
HSE 
The development of the NDRF elearning has been completed final quality control 
check delayed due to Covid.  The SAOR screening and brief intervention, for 
problem alcohol and substance use, train the trainer programme was completed.   
 
Virtual classroom version of SAOR training, elearning is available on HSELand 
2.1.13  
Expand the availability 
and geographical 
spread of relevant 
quality drug and 
alcohol services and 
improve the range of 
services available, 
based on identified 
need. 
2.1.13 (a)        
Identifying and 
addressing gaps in 
provision within 
Tier 1, 2, 3 and 4 
services;                            
HSE 
Gaps in provision in Tiers 1 to 4 have been identified, and work progressed in 
2020 to address these gaps.    
CHO1: Governance gaps addressed via recruitment of Clinical Lead and 
Assistant Director of Nursing (ADON) currently in progress. Alcohol liaison 
post in Sligo filled via agency. Cavan/Monaghan service enhanced with 5 day 
service provided by counselling, nursing, admin team  
CHO2: Outreach gap addressed via 2 new project workers operating at full 
capacity. Community Alcohol service currently recruiting staff and sourcing 
premises. 
CHO3: Waiting list addressed via new treatment services established and 
operational in Limerick and Ennis. Hep C treatment supported in Limerick 




addressed via additional counselling post and enhanced needle exchange. 
CHO5: Governance gap addressed with commencement of recruitment of 
Clinical Lead. Treatment gap addressed with new service in Gorey and South 
Tipperary. Overall capacity increased by 60 
CHO6 & 7: Governance gap, Director of Nursing advertised and awaiting 
interview. Clinical gap addressed with move of Cuan Dara to St Lomans site, 
delayed due to Covid – anticipated in 2021. Clinical gaps addressed with new 
services in Kildare and Newbridge. New service planned for Athy, being 
renovated. Daisyhouse service is fully operational. 
CHO8: Clinical need and waiting list addressed via new clinics in the Midlands 
area. Now operational in Tullamore, Longford, Portlaoise and Mullingar. 3 new 
virtual clinics established to deal with increase in numbers. Governance being 
addressed via recruitment of ADON. 
CHO9: Governance addressed with Clinical lead post interviewed for and 
offered - Pending start date.  
 
Service gaps identified and supported via Suimhneas, Ashleigh House PUP 
programme, Recovery Academy and UISCE.   Response by HSE Addiction 
Services, to the Covid pandemic, has resulted in the rapid initiation of 863 
additional clients onto OST in 2020.  
  




provided across the 
range of services 
available, 
including: 





HSE Addiction Services response to the Covid pandemic has resulted in the 






2.1.13 (c)  
Strengthening the 
capacity of services 




Guidelines on the rapid induction of clients to treatment developed in Q1 and 
modified in response to the ongoing pandemic. Safety net increased numbers in 
attendance. 
CHO3: 
Alcohol liaison nurse: Expand mental health services for people with alcohol 
addiction presenting in acute hospitals: Dual qualified mental health nurse 
(Governance through mental health), Work is ongoing in partnership with Mental 
Health Services to develop the model for integrated care between MH and 
community services and to fill the post  
CHO4: 
Mental health collaboration progressing with Alcohol Liaison nurse appointed 
and current recruitment of a Consultant Psychiatrist for service and under 18 
Clinical Nurse Specialist 
CHO9: 
Recruitment processes in place for posts in relation to MH and Addition services 
in relation to Alcohol Liaison Nurse, 0.5 Consultant Psychiatrist and 5 Dual 
Qualified Mental Health nurses including 2 specifically for NEIC.  
 
 
2.1.14 Improve the 






increase access to 
OSTs such as the 
expansion of GP 
prescribing, nurse-
led prescribing and 







Guidelines prepared for rapid induction of clients to treatment     
 • The additional tier 3 expansion as outlined in 2.1.13(a) in CHO1, 3, 5, 6/7, 
8.  
• Guidelines on the rapid induction of clients to treatment developed in Q1 
and modified in response to the ongoing pandemic.  
• Virtual clinics established in CHO8 for GP prescribing to reduce waiting 
times.  
• Amendments to Misuse of Drugs regulations to allow for the electronic 
transfer via Healthmail between GPs and Pharmacies to reduce waiting 
times.  
• Availability of OST was widened extensively and additional homeless 
settings were able to engage people on OST. Total in treatment end Dec 
2020: methadone 10,935 individuals, total Suboxone 423 individuals, a total 
increase over 2020 of 863 people on OST. 
• All areas in the country addressed need during the Covid pandemic accessing 
additional people into treatment via new clinics, increasing capacity and 
establishing new clinics with innovative ways of working.  
Green 
2.1.15  
Enhance the quality 
and safety of care in 






on OST and 








• Ongoing adherence to the OST guidelines continued across all CHO areas 
and the non-direct supervision of urines has become established.  
• New guidelines and advice on OST were developed and circulated to 
Clinicians in order to facilitate the safe, rapid induction of a large number of 
people onto OST.  
• The Guidelines in relation to the provision of OST in the Hospital setting 
were formally circulated by the HSE to all Acute and Mental Health 
Hospitals.  
• Guidelines around safe delivery of OST to individuals who were required to 
self isolate as a result of the Covid pandemic were issued.  
• Guidelines in relation to tele counselling/assessment were issued to services.  
• Other guidelines to enhance safety of care in the delivery of OST were issued 




Management for Isolation Units, Safe Supply of Medicines during Covid 19, 
Overdose Response and Naloxone Guidance, methadone take home leaflets, 
guidance document for homeless and vulnerable people  
2.1.16 Improve 




range of peer-led, 






• Continuing to support the work of SMART Recovery Ireland and the 
Recovery Academy of Ireland.  
• Specific resources developed and disseminated on drugs.ie on maintaining 
recovery during the stressful period of the Covid Pandemic.  
• Supported the development of the DoH guidance for drug and alcohol 
support groups and treatment programmes and other addiction treatment 




strengthen services to 
support families 
affected by substance 
misuse 











TUSLA provides a small grant for Bereavement counselling. Due to Covid19 
Restrictions the programme was cut short, the facilitation of this programme in 








to address child to 
parent violence 
TUSLA 
Covid Restrictions halted any hosting of this training however it is now 
available online and will be facilitated in 2021. 
  




people in their 
TUSLA 
NFSN in partnership with Treoir/Family Resource Centres & Kinship Carers 
established a new project 'Kinship care Ireland' - hosted by Treoir, 1 full time 
worker funded by Tusla. FSN provided recruitment and strategic planning 
support and remains on the steering group of the project. 
 
 
family as a result of 







by substance misuse 

















• Several online video meetings were held with the CE Drugs Advisory Group 
throughout the year with actions identified                                                                       
• Schemes have continued, where possible, to help those affected by substance 
abuse to continue to build recovery capital.                                              
 
Stakeholder Meeting are continuing to take place with emphasis being placed on 
developing DRP’s in the regions. Consideration is being given to Participants of 
DRP’s to extend their contract to allow them to retain their programme through 
the Covid 19 pandemic. Programmes continue to be delivered to individuals 





Utilising SICAP to 
improve the life 
chances and 
opportunities of 
those who are 
marginalised in 
society, living in 







• The COVID-19 restrictions had an impact on the delivery of activities in 
2020. However, LDCs were able to provide some supports and to offer 
services online/by phone. Many activities in 2020 were continued from 2019 
and included: 
- Engaging with other stakeholders (e.g. drugs & alcohol tasks force, drugs 
prevention committees, treatment and rehabilitation / counselling services, 
etc.) working to address drug and alcohol abuse in the community.  
- Mental health and wellbeing initiatives 
- Counselling and personal development services 
- Life skills and training 








• Substances misusers are not a named target group of SICAP but 5 of the Lot 
areas (51 lot areas across the country) have identified substance misuse as an 
emerging need group in their area for 2020. 
• A total of 190 individuals with substance or addiction issues to date (2018-
2020) received direct one-to-one supports. 
• 5 local community groups working with people affected by substance 
abuse/misuse were also supported to date (2018-2020). 
2.1.19 Increase the 
range of progression 
options for recovering 
drug users and 
develop a new 
programme of 
supported care and 
employment. 
Establishing a 
Working Group to:   
 a) Examine the 
range of 
progression options 





key skills training 
and community 
participation with a 
view to developing 
a new programme 
of supported care 
and employment; 
and     
 b) Identify and 
remedy the barriers 






On hold awaiting publication of inter-departmental report on social inclusion 










barriers and the 
lack of childcare 
provision, for those 
in recovery. 
2.1.20    Expand 
addiction services for 








Medical social workers approved and funded by NWIHP in 2019 for maternity 
services around the country continued to be recruited into and filled.   
 
Maternity teams based in acute sites continued to work with and develop 
relationships with newly appointed drug and liaison midwives within the CHO 
areas.                 
 
Limerick Mid-West Service operational, PUP therapist, 5 keyworkers & 2 
childcare workers to support and remove barriers to treatment. Services delivery 
includes- pre-entry and aftercare groups.  
 
Roll-out  of PUP training  to develop a community of practice in the area to 
support mothers due April 2021. 
 
  
2.1.20(b)     






who need in-patient 
treatment for 
addiction to drugs 
DOH 
One mother and child residential treatment service available in Dublin, with 
exercise undertaken to identify additional residential placements required.  




across the country; 
 
2.1.20(c)     
Develop services 
to meet that need 
ensuring that such 
facilities support 
the development of 
the mother-baby 
relationship; 
DOH Being developed as part of expansion of Alcohol and Drug Liaison MidWives 
 







examining the need 
to expand the role 
of the Drug Liaison 
Midwife (DLM) in 
this regard. Any 
such expansion will 
likely generate a 
need to further 
increase the number 
of such midwives; 
DOH 
Funding was secured to employ a drug liaison midwife in every CHO area                                                           




2.1.20(e)     
Resource the 
National Women 







workers in all 
maternity networks; 
DOH 
Funding approved by NWIHP for Medical social worker for maternity services 
around the country.  Recruitment process continues and posts are being filled.  
Maternity teams based in acute sites continued to work with and develop 
relationships with newly appointed drug and alcohol liaison midwives within 
the CHO areas. 
 








to reduce their 
intake; and 
DOH 
A specific Making Every Moment Count learning module for maternity 
services was developed in Q4 2020.  This module is due to be launched in Q1 
2021.  The MEMC programme for maternity services is targeted at supporting 
and enabling staff to use every opportunity of contact with women to support 
and educate them and provide them with information in relation to their 
physical and mental wellbeing, and addresses such areas as alcohol, smoking 
and drug misuse and addiction as appropriate.  Women detected at any point in 
their care pathway as engaging in drug and alcohol abuse are offered access to 
the required support services to support them reduce their intake. 
 
2.1.20(g)     
Engage the 




about the risks of 
alcohol 
DOH 
In addition to the maternity specific module in the MEMC programme, all 
women engaging with maternity service undertake a one-on-one booking-in 
clinic in which a detailed assessment and history is taken of the woman with a 
standard list of areas covered and reviewed including alcohol, substance misuse 
and smoking.  At this clinic, women are informed of the associated risks of 
such behaviour, with additional referrals being arranged as needed to support 
services and information sources being clearly identified for the women.   
Throughout their care pathway in maternity services, required information and 
advice will be re-iterated with continued availability for referrals to support 





2.1.21   Respond 
to the needs of women 
who are using drugs 
and/or alcohol in a 
harmful manner. 






to meet the needs of 
women who are 
using drugs and/or 
alcohol in a 
harmful manner, 
including those 
with children and 
those who are 
pregnant 
HSE 
• Recruitment of drug and alcohol liaison midwives was delayed due to 
COVID, however some progress has been made. Recruitment in process in 
CHO1, CHO2, CHO4 and CHO5.  In CHO3, the work of this post is 
currently being progressed via the clinic nursing team / agency nursing 
including active case load of pregnant clients; liaison work with the 
Maternity Hospital and perinatal mental health team and a range of targeted 
sexual health / women’s health interventions. CHO8 at initial planning 
stages of governance and recruitment.    
• Residential service for women Limerick - The community-based aspect of 
this service commenced in 2020, with the team recruited and city centre 
premises up and running.  Coolmine TC are at an advanced stage with 
Limerick City & County Council in relation to the planning for the 
residential site, with work on the spec for the e-tender for the refurbishment 
of the site due to start. 
Green 
  
2.1.21(b)   
Develop 
interventions to 
address gender and 
cultural specific 
risk factors for not 
taking up treatment.  
HSE 
• Supported research by Sarah Morton on responding to women with 
complex needs who use substances.  
• COVID 19 migrant health sharing hub set up 
https://www.hse.ie/eng/about/who/primarycare/socialinclusion/intercultural-
health/covid-19-sharing-resources-migrant-health.html   
• About the Irish Health System- a guide for refugees and other migrants 
reviewed, updated and translated to 14 languages 
https://www.hse.ie/eng/about/who/primarycare/socialinclusion/about-social-
inclusion/translation-hub/multilingual-resources-and-translated-material/ .  
• In the period March to December 2020 188 leaflets, posters and translations 
produced for vulnerable groups. 
 
 
• The new eLearning programme, ‘Introduction to Traveller Health’ is now 
available on hseland.ie. The module was developed by the South East 
Traveller Health Unit for all HSE staff and staff of HSE funded 
organisations across the country to support a greater understanding of 
factors that influence Traveller health and to support staff to play their part 
in providing a more inclusive and culturally competent service to members 
of the Traveller Community. The training is available under the ‘Personal 
Effectiveness Skills’ section on www.hseland.ie. 
2.1.22 Expand 
the range, availability 
and geographical 
spread of problem 
drug and alcohol 
services for those 
under the age of 18. 
2.1.22(a)  
Identifying and 






Pilot telepsychiatry support service now operational and Consultant Child and 
Adolescent Addiction psychiatrists providing input to specific areas. This will 











Cavan Monaghan began recruitment through S.39 to recruit a Clinical Nurse 
Specialist to enhance multi-disciplinary Tier 3 Addiction Team for Under-18s.   
CHO2 Clinical Nurse Specialist through S.39 to enhance multi-disciplinary 
Tier 3 Addiction Team for Under-18s.  
In CHO3 recruitment began for a Clinical Nurse Specialist to enhance multi-
disciplinary Tier 3 Addiction Team for Under-18s.  
In CHO4 recruitment began for an under 18 Clinical Nurse Specialist. 
 In CHO5 recruitment began for a Clinical Nurse Specialist to implement new 
model of service delivery for adolescent addiction services and enhance 
governance structures. 
  





substance use and 
HSE, 
TUSLA 
Telepsychiatry pilot in place to enhance interagency working, pilot in 5 areas 
 
 
child and family 
services. 
2.1.23   Improve the 
response to the needs 
of older people with 
long term substance 
use issues. 
Examining the need 
for the development 
of specialist 
services to meet the 
needs of older 
people with long 
term substance use 
issues. 
HSE 
Research in relation to needs among older people with long term substance use 
issues delayed due to Covid-19 
Red 
2.1.24  Improve 
outcomes for people 
with co-morbid severe 











A decision was taken to reconstitute the Mental Health Clinical Programme to 
address dual diagnosis.  A clinical lead and programme manager for the 
Programme have been offered positions and have accepted.  Currently awaiting 







services and drug 
and alcohol 





planning in line 
HSE 
Dependent on progress of the mental health clinical programme.                                                                   
 
In CHO3 work was ongoing, in partnership with Mental Health Services, to i) 
develop the model for integrated care between MH and community services and 
recruit and Alcohol liaison nurse and dual qualified mental health nurse.                                                         
 
Development of community mental health service NEIC: 1 Dual Qualified 
Mental Health Staff Nurse recruitment is in progress.                                                                
 
In CHO5 an addiction Counsellor employed through Section 39 agency while 
recruitment through NRS progresses 
 
 
with the National 
Drug Rehabilitation 
Framework. 
2.1.25  In line with 
Rebuilding Ireland, 
improve the range of 
problem substance use 
services and 
rehabilitation supports 
for people with high 









• New Stabilisation unit opened in North Dublin Inner City.  
• COVID19 presented opportunities for interagency and intersectoral working 
to provide support for people with high support needs who are homeless.  
• Residential services nationally impacted significantly by Covid 19 due to 
public health restrictions, in particular the impact of these in older facilities.   
• Webinar on maintaining Tier 4 services during the pandemic, for Tier 4 
service providers, delivered by Dr. Eamon Keenan and Dr. Joe Barry.  
• Webinar on maintaining services for vulnerable groups, specific to 
addiction services, delivered to addiction service providers, delivered by Dr. 
Martin Cormican.  
• Additional funding sought through estimates process for additional services 







planning and case 
management. This 
entails person-
centred holistic care 
planning, including 
identifying and 
building social and 
recovery capital; 
HSE 
Evaluation of pilot implementation of the combined assessment and care 
planning document and full implementation delayed due to COVID.                  
 
Ongoing local delivery of key working, care planning and case management 
training established, for example - CHO5: All new staff complete Care & Case 
Management training as part of their induction.          
 
Re-establish Care & Case Management Governance Groups in each county in 
SECH.                                                              
 
Continue to engage with homeless services in SECH in the implementation and 
evaluation  of the Homeless/drug and alcohol combined documentation pilot.                                                                        
 




Dual Diagnosis care planning group facilitated in the NDTC provided support on 









discharge to ensure 
that housing and 
supports are in 
place; 
HSE 
In accordance with the NDRF, pre treatment and post treatment care plans are 
agreed.  Case management continues to ensure the needs for housing and 
supports are identified on discharge.  This is a condition of purchased episodes.   
 
The review of the Homeless Hospital discharge protocol was paused due to 
Covid. 
  















services, so that the 
drug rehabilitation 




Housing First enables people who may have been homeless and who have high 
levels of complex needs around mental health or addiction to obtain permanent 
secure accommodation with the provision of intensive supports to help them 
maintain their tenancies.    
 
The Housing First National Implementation Plan published in September 2018, 
is designed to provide this response, by delivering permanent housing solutions 
and associated supports for rough sleepers and long-term users of emergency 
accommodation.  The plan contains targets for each local authority, with an 
overall national target of 663 tenancies to be delivered by 2021.   
 
2020 saw the extension of the programme to the remainder of the country with 
contracts and tenancies now in place in every region. 208 individuals entered the 
programme in 2020 and 508 tenancies were in place nationally by the end of 
2020 (392 of which were created since the introduction of the Plan). A National 
Implementation Group including representation from the Department of 
Housing, Planning and Local Government, the Department of Health, the HSE, 
Local Authorities, and the National Director, oversees the planning and delivery 








The Programme for Government commits to continue to expand the Housing 
First approach with a focus on the construction and acquisition of one-bed homes 
and the provision of relevant supporting services. Research is being undertaken 
by the Housing Agency to carry out an assessment of need for the supports 
provided by Housing First which is being used to inform the expansion of the 
Programme.   
  
2.1.25(e)      
Developing the 
provision of gender 
and culturally 
specific step down 
services, 
particularly 
housing, for women 




treatment who are at 




Suaimhneas, Daisy House, PMcV  and Coolmine Ashleigh House continue to 
provide specific step-down for women.  
2.1.26   Intervene 
early with at risk 








onward referral in 
line with national 
screening and brief 
intervention 
IPS, PS 
SAOR training continued to be rolled out, focusing in on newly appointed staff 









Further develop the 
range of service 
specific problem 
substance use 





Delay in completion of Drug survey report due to data issue / COVID. 




prevalence of NPS 
use in prison 
settings with a view 
to developing 





Drug survey report will provide detail in relation to prevalence of NPS use 
among probation cohort. NPS will be addressed as part of a workplan 
developed on foot of research findings. 
2.1.27  Improve the 
capacity of services to 
accommodate the 
needs of people who 










working with them, 
as appropriate; 
HSE 
Completion of Traveller-specific SAOR Screening and Brief Intervention for 
Problem Alcohol and Substance Use.   In a conjunction with Pavee Point, HSE 
developed resources on alcohol use in pregnancy, alcohol use during Covid and 
alcohol in general.   
 















need for specialist 
referral pathways 
for specific groups 








The Club Drugs Clinic Ireland (G Clinic) provides a detoxification programme, 
support or advice for people who are dependent on GHB, GBL & Crystal Meth. 
Provision was allocated to expand the G Clinic which included the provision of 
a counsellor and doctor.      
 
The G Clinic closed during the first COVID -19 lockdown in 2020. Following 
the development of new COVID – 19 compliant protocols alongside a newly 
designed clinic space, the service reopened in August 2020 and remains 
operational.                                      
 










• In addition to Module 1 (Inclusive Practices and Intercultural Awareness) 
and Module 2 (Working with Others), Module 3 on Intercultural 
Awareness and Practice in Health and Social Care: Refugees, Protection 
Applicants and Trauma was developed in 2020 and made available on 
HSELand. 
• 1476 staff have completed all three modules of the Intercultural Awareness 





services engage in 
ethnic equality 








of service users for 




2.2.28  Continue to 
expand Harm 
Reduction Initiatives 
focused on people 





HSE Ongoing needle exchange supported nationally, by voluntary and statutory 
services.  Guidance document on needle exchange during Covid pandemic 
produced.    
Blue 
  




treatment for blood 




BBV screening has been provided for all new entrants onto OST in 2020 
  
2.2.28 (c)  
Increase the uptake 
of Hepatitis C 
treatment. 
HSE 
HepC treatment programme for people who use drugs attending addiction 
services has re-commenced and is expanding. 
2.2.29  Provide 
enhanced clinical 
support to people who 
inject drugs and 





Planning application for a SIF was approved by An Bord Pleanála however this 
has been challenged and is subject to a Judical Review.  
 




mitigate the issue of 
public injecting. 
effectiveness of the 
initiative. 
2.2.30   Continue to 












measures to target 






Overdose awareness continues to be targeted at addiction services and high-risk 
cohorts of people who use drugs.   
 
Information is updated on a regular basis as new trends emerge.  A joint 







Naloxone to people 
who use drugs, 
their peers, and 
family members; 
HSE 
Naloxone availability significantly enhanced in 2020. Provided similar amounts 
of Naloxone in first 4 months of 2020 as in whole of 2019. Ongoing delivery of 
naloxone & training to staff, clients and family members. Training has been 
amended in light of Covid 19. Training provided in prison services.  
 
Naloxone resources developed for COVID-19 and available on drugs.ie.  PCRS 









Recovery and other 
relevant strategies 




primary aim is to 
reduce suicide rates 
in the whole 
population and 
amongst specified 
priority groups; and 
DOH 
Worked with Mental Health partners to promote recovery as per the revised 
mental health policy ‘Sharing the Vision’ which notes the need to provide access 





to staff working 
with young people 
in the area of 
alcohol and 





On-going collaboration with NOSP on suicide prevention training for addiction 






Goal Three: Address the harms of drug markets and reduce access to drugs for harmful use. 
 
RHSR Strategic 









3.1.31  Keep 
legislation up-to-date 
to deal with emerging 
trends in the drugs 
situation. 
Keeping legislation 
under review, against 
the background of 
national, EU and 
broader international 
experiences and best 
practice, to deal with 
emerging trends, 
including:   
a) new synthetic 
substances;  
b) new or changed uses 
of psychoactive 
substances; and   
c) the evolving 
situation with regard to 
drug precursors and the 
surface web and dark 
net drug markets. 
 DOH, DJE 
On-going monitoring of international trends regarding NPS and 
harmful substances from the EMCDDA, EU and other relevant 
source.  Legislation reviewed 
Green 
3.1.32  Reduce rates 
of driving under the 
influence of drugs. 
Implementing the 
measures relating to the 
testing of drivers for 
drugs and alcohol DTTAS 
Action completed as measures have been implemented since 




contained in the Road 
Traffic Act 2016. 
 






the Final Report of the 
Working Group on a 
Strategic Review of 
Penal Policy of July 





3.1.34  Map the future 
direction and 
objectives of the Drug 
Treatment Court. 
3.1.34(a)  
Carrying out an 
independent evaluation 




Amber   
3.1.34(b)  
Continuing to support 
the operation of the 
Drug Treatment Court, 
having regard to the 
recommendations made 
in the 2013 review, 




3.1.35  Consider the 
approaches taken in 
other jurisdictions to 
the possession of 
Establishing a Working 
Group to consider the 
approaches taken in 





small quantities of 
drugs for personal use 
with a view to making 
recommendations on 
policy options to the 
relevant Minister 
within 12 months. 
the possession of small 
quantities of drugs for 
personal use in light of 
the Report of the Joint 
Committee on Justice, 
Defence and Equality 
on a Harm Reducing 
and Rehabilitative 
approach to possession 
of small amounts of 
illegal drugs. 
3.2.36   Support the 




markets, in particular 
new drug markets, 
surface web and 
darknet drug markets. 
Investing in capacity 
building measures to 
support the role of law 
enforcement authorities 
in monitoring drug 
markets, in particular 
new drug markets, 
surface web and 





The Garda Síochána continue to engage with the EWET sub-
committee and provide relevant data to the EMCDDA. 
Information provided to the EMCDDA forms part of their Annual 
Report and Irelands Country drug report. 
 
The Garda Síochána continue liaison at EU level regarding EU 
trends of controlled drugs & darknet including participation on 
the European multi-disciplinary platforms Against Criminal 
Threats (EMPACT) for the Operational Action Cocaine, 
Cannabis and Heroin.      
 
The Garda Síochána continue to engage with the Revenue 
Customs Services and the Health Products Regulatory Authority 
in respect of online drug markets.                                     
 
The Garda Síochána continue to collaborate at national level and 
at international level with law enforcement partners.                                                                       
 
The Garda Síochána currently hold the presidency of the 
Pompidou Group.    Green 
 
 
3.2.37   Consider the 
case for the use of 
Community Impact 
Statements within the 
Criminal Justice 
System in Ireland. 
Subject to the 
completion of the 





their implementation. AGS  
The Garda Síochána have held meetings with relevant 
stakeholders under this Action, including with the Department of 
Justice and the assessment has been completed.  
Recommendations were submitted to the Standing sub-committee 
(SSC) of the National Drugs & Alcohol Strategy in early 
December 2020.    As part of the recommendations, it is envisaged 
that a new Action may be established in 2021.   
Green 
3.3.38  Strengthen the 
response to the illegal 
drug market, including 




Continuing to develop 
systems to monitor 
changing drug trends in 




• 3 EWET meetings were held in 2020 in which attendees 
exchanged the latest information to hand in their respective 
areas/organisations. Information is also exchanged between 
group members throughout the year as matters arise.                                                                                                                                    
• Due to Covid no meeting was held in 2nd quarter. 
• Meetings held in 3rd and 4th quarter carried out successfully 





development of the 
HSE public alert system 
for adverse events due 
to drugs and 
commencing 
implementation; 






tasked with analysis of 
drugs of abuse, to 
engage in novel 
DPER, 
DTTAS 
While Sport Ireland does not operate its own laboratory for anti-
doping, the agency supports developments in analytical methods 





work, in relation to 
psychoactive drugs but 
especially new 
psychoactive 
substances (licit or 
illicit), while continuing 




Providing funding in 
the capital expenditure 
programme for the 
construction of a 
purpose-built new 
laboratory for Forensic 
Science Ireland with 
€6m prioritised to 
commence the project 
immediately 
DJE Project substantially advanced and on target in 2020 despite 
impact of Covid 19.    
 
3.3.38(e)  
Strengthen the legal 
robustness of 
Presumptive Drug 
Testing (PDT) to 
contribute to the timely 




A proposal to put the Presumptive Drug Testing (PDT) scheme on 
a statutory basis has been submitted to DOJ by FSI. It is currently 







Goal Four: Support participation of individuals, families and communities 
RHSR Strategic 









4.1.39   Support and 
promote community 
participation in all 




participation in all 
local, regional and 
national structures. 
DOH 
DoH continued to support Citywide, NSFN, UISCE and NVDAS 
in their participation in these structures.   
DoH continued to engage with these groups as required. 
Green 
4.1.40  Measure the 
impact of drug-related 
crime and wider public 
nuisance issues on 
communities. 
Developing and 
piloting a Community 
Impact Assessment 
Tool in order to 
measure the impact of 
drug-related crime and 
wider public nuisance 
issues on communities. 
C&V sectors 
The evaluation of the pilot phase was completed in July and was 
launched, along with resource materials for use of the Tool, at an 
event in November attended by the Garda Commissioner. The 
resource materials have been widely circulated and workshops 
will be organised in 2021 to support local groups who are 
interested in using the Tool in their local/regional areas. 
Blue 
4.1.41  Enhance the 
relationship between 
an Garda Síochána and 
local communities in 
relation to the impact 
of the drugs trade. 
Building on the 
achievements of Local 
Policing Fora in 
providing an effective 
mechanism for building 
and maintaining 
relationships between 




Following the recommendations of the CoFPI report, the 
Department of Justice has been developing a new Community 
Safety policy which will introduce new structures to strengthen 
relationships between local communities and service providers, 
including AGS, which will prioritise community concerns, and 
will strengthen inter-agency cooperation. In 2020 arrangements 
were made to test-run the new policy and structures in three pilot 
sites across the country and to rigorously evaluate the pilots. This 




the local communities, 
in particular in relation 
to the impact of the 
drugs trade. 
departments and agencies. This preparatory work has been 
ongoing in 2020 and the pilots will be launched in 2021. 
                                                                            
As part of the implementation of the Commission on Future of 
Policing in Ireland report, national and local coordination 
structures for Community Safety are being developed with a view 
to enhancing inter-agency cooperation, community engagement 
and feedback in relation to issues of local concern, including 
drugs crime. The Garda Síochána continues to build a positive 
Community Policing ethos. 
 
The Garda Síochána continues to recognise the importance of 
addressing the issues of drugs and in particular drug related 
intimidation by working with the JPCs and LPF with a view to 
devising an appropriate and sustainable local response to such 
issues. This is an on-going effort achieving a broadening message 
by way of information sharing with relevant partners. 
 
The Garda Síochána continue to deliver National Drug Strategy 
awareness training within An Garda Síochána to nominated 
members from divisions at the Garda College. To date 60 
members have received National Drug Strategy training. 
(Training restricted by COVID 19 in 2020).                                                                             
 
In 2020 the Garda Síochána assisted the Community and 
Voluntary Sector in meeting their obligations under Action 
4.1.40 of the National Drug Strategy which relates to Community 
Crime Impact Assessments (CCIA). Such Actions contribute 
towards The Garda Síochána's mission of 'Keeping People Safe'. 
 
 
4.1.42  Strengthen the 




An Garda Síochána and 
the National Family 
Support Network will 
each carry out its own 
evaluation of the Drug-
Related Intimidation 
Reporting Programme 
to strengthen its 
effectiveness and, if 
appropriate, develop 
measures to raise public 
awareness of the 
programme. 
AGS, NFSN 
NFSN evaluation completed/ drug-related intimidation training 
was adapted online - 2 sessions provided in 2020, Recruitment 
for DRI post postponed but finalised in October 2020- Survey 
sent to local DATF.                                                                                                                                                                                 
The Garda Síochána met their obligations under this action by 
end 2018. In furtherance to the implementation of the action in 
2020, the Garda National Drugs and Organised Crime Bureau 
(GNDOCB) facilitated a Drug-Related Intimidation seminar with 
the National Family Support Network (NFSN), nominated 
Inspectors & Drug and Alcohol Task Force Inspectors 
countrywide in February 2020. The seminar was hosted by 
Assistant Commissioner John O Driscoll.                                                              
The Garda Síochána are represented on the DRIVE Project 
Committee and continue to engage in meetings on the 
development of a framework for inter-agency collaboration on 
drug related violence and intimidation.                                                                    
The Garda Síochána continue to support & liaise with the NFSN 
and other agencies in relation to the Drug Related Intimidation 
Reporting programme.                    
The drug-related intimidation posters have been distributed to 
every Garda Station countrywide to promote on-going 
awareness.                                    Green 
 
 
Drug Related Intimidation is included as a module in the National 
Drug Strategy Training in which sixty members have been 
trained to date.                                              
As part of the strategy to address Drug Related Intimidation, a 
pilot project is currently being undertaken in the DMR West and 
DMR North Divisions to develop information to facilitate an 
evidence-based analysis of drug-related intimidation, for the 
purpose of gaining an more focused understanding of the issues 
relevant to drug-related intimidation and improve the 
effectiveness of the Drug Related Intimidation Reporting 
Programme and the response to drug-related intimidation in 
communities. 
4.2.43   Build capacity 
within drug and 
alcohol services to 
develop a patient 
safety approach in line 
with the HIQA 
National Standards for 
Safer Better 
Healthcare. 
Requiring the delivery 
of services within a 
Quality Assurance 
Framework, which will   
a) standardise services;   
b) include basic tools in 





c) reflect a human 






4.2.44   Promote the 
participation of service 
users and their 
families, including 
those in recovery, in 
local, regional and 
national decision-
making structures and 
networks in order to 
facilitate their 
involvement in the 
design, planning and 
development of 






models of participation 
in line with best 
practice. 
DOH 







Goal Five: Develop sound and comprehensive evidence-informed policies and actions. 
 
RHSR Strategic 













Continuing to monitor 
the drug situation and 




and existing data 
collection systems, 
while ensuring that 
Ireland can respond to 
new data monitoring 
requests arising from 
the Oversight and the 
European Union during 




Data for 2019 submitted to the EMCDDA included drug 
treatment data, prevalence of hepatitis B/C and HIV infection 
among injecting drug (IDUs) users and data re pharmacy-based 
needle exchange services.            
Most recently available data on drug seizures and drug-related 
offences were submitted to the EMCDDA in October.                                                                         
Data on drug treatment in prisons were included in the HRB’s 
report on prisons to the EMCDDA.                                                                  
Data on 2018 drug-related deaths (the latest year) were not 





















include the monitoring 
of attendances as a 
result of alcohol and 





The hospital Patient Administration System (PAS) has the 
facility to record reason for attendance.   
  
5.1.45(d)  
Developing a suitably 
integrated IT system 
which allows for the 






Individual areas progressing bespoke IT systems. Fully 
integrated IT system for addiction service dependent on 
implementation of an IHI. 
5.1.46  Support 
evidence-informed 
practice and service 
provision. 
5.1.46(a)  
Ensuring that public 
funding is targeted at 
underlying need and 
supports the use of 
evidence-informed 
interventions and the 
evaluation of pilot 
initiatives; 





Designating the Health 
Research Board as a 
central information hub 
on evidence on the 
drugs situation and 
responses to it; 
 




mechanisms are in 
place to communicate 
this evidence in a 
timely manner to those 
working in relevant 
healthcare settings, 





5.1.46( d)  
Developing 
collaborative 
relationships with third 
level institutions in the 
area of drugs and 






5.1.47  Strengthen the 
National Drug 
Requiring all publicly 
funded drug and 
alcohol services to 
DOH, DJE 
HRB have analysed NDTRS to establish the percentage of drug 
and alcohol services known to HRB that should be returning 






complete the NDTRS 
for all people who use 
services. 
coverage in 2018 and 69.6% in 2019.  Data in respect of 2020 is 
being validated. 
Analysis also indicates that coverage for different types of 
services differs, for example in 2019, the overage for inpatient 
services =  90.2% but for OST GPs = 44.2%. 
5.1.48  Develop a 
prioritised programme 
of drug and alcohol-
related research on an 
annual basis. 
Harnessing existing 
data sources in the drug 
and alcohol field in 
order to enhance 
service delivery and 
inform policy and 
planning across 
government and the 
community and 
voluntary sectors, and 
having done so, identify 
deficits in research in 
the field to enable the 
development of a 
prioritised programme 
on an annual basis. 
DOH 
HRB's 2020 research and monitoring programme approved.  
Data collection on general population survey completed in 
March. Data delivered to HRB for analysis and report on 
findings of survey is being prepared.  A number of next studies 
have commenced, including an overview of young people and 
substance use and a census of homeless deaths using NDRDI 
methodology.                                                                                      
The Secondary Data Analysis Project (SDAP) is a HRB funding 
scheme supporting research that answers policy and/or practice-
relevant questions through the use of secondary data. The award 
supports research projects in clinical research, population health 
research and/or health services research where the findings from 
the research will have direct relevance to policy and/or practice 
in the Irish health and social care system. 
This should involve close collaboration of researchers with non-
academic stakeholders (policy makers and data controllers). 
Proposals must include at least one existing Irish or 
International dataset in order to be eligible for this call. The 
award will be for between 12 and 24 months. The HRB 




and Funding unit are examining a proposal to allocate one 
SDAP award to a drugs specific theme, supported by funding 
from the Department of Health.  The HRB will process 
applications for this award in the same manner as applications 
in other research areas.    




Undertaking a study on 
rehabilitation outcomes, 
which takes into 
account the experience 
of service users and 




building on work 
already undertaken. 
DOH, HRB 
HRB commissioned a scoping review on international 
rehabilitation outcomes reseach and recommendations 





The final action aims to strengthen the performance of the strategy.  
RHSR Strategic 









6.1.50  Develop an 











voluntary sectors and 
strengthen the Drug 
and Alcohol Task 





Phasing in the 
introduction of a 
resource allocation 
model (RAM) to 
achieve a more 
equitable distribution of 
resources across Task 
Force areas. This will 
involve monitoring and 
assessing the evidence 
from the operation of 
the RAM on an annual 
basis 





significant changes in 
problem drug or 
DOH 
Stakeholder engagement with DATFs event took place in Q3 2020, at 
which DPU outlined plans for the development of a Needs Assessment 
and Service Requirement Tool as a key component of the Performance 
 
 
alcohol use are found 
from one year to the 
next, or differences are 
observed between 
areas, and analysing 
why such differences 
have emerged with a 
view to successfully 
implementing the 
strategy and assisting 
DATFs improve their 
actions and 
interventions over time; 
Measurement System. Detailed consultation has only taken place with 
one of the authors of the Trutz Haase report to explore what options 
may be available to further develop this piece of work. A detailed work 
plan is being considered for 2021.       
  
6.1.50(c) 
 Improving the 
alignment of Task 
Force boundaries    
DOH Not commenced 
  
6.1.50(d)  
Ensuring that Task 
Forces have appropriate 
arrangements in place 
for the selection and 
renewal of the Chair 
and members of the 
Task Force and have 
proper procedures in 
place for addressing 
conflict of interest; 
DOH Preparatory work commenced on Governance Code. 
  
6.1.50(e)  
Building the capacity of 
DATFs to participate in 
DOH 
Next stage following the development of the Performance 






6.1.50( f)  
Coordinating a cross-
Departmental approach 
at national and local 
level to allow for the 
gathering of the 
appropriate information 
and data streams to feed 
into the ongoing 
organic further 












Appendix 2 - list of stakeholder engagements 
 
Department of Justice 
Probation Service 
Irish Prison Service 
An Garda Síochána 
Revenue’s Custom Service 
Health Research Board 
Department of Housing 
Department of An Taoiseach 
TUSLA 
Department of Education and Skills 
Department of Rural and Community Development 
Health Service Executive 
Community Sector – Citywide, UISCE, NFRN, BeLonGTo, Pavee Point 
National Voluntary Drug and Alcohol Services 
Drug and Alcohol Taskforces Networks 
Department of Health 




Appendix 3 – Strategic Priorities, with relevant RHSR goals 
Strategic Implementation Groups   
# 
Strategic 
priority RHSR goal Policy alignment 
Programme for Govt 
commitments 
EU Drugs 
Strategy Outcomes Members 
















Public Health                                   
UN Rights of the 
Child #33                 
National Children's 
Strategy                 
Sláintecare reform 
programme 1 
(healthy living)                       
UN Sustainable 
Devt Goal 3 (target 
3.5)                                       
* Introduce drug & 
alcohol awareness 
programmes in schools                                                                                     
* Resource harm 
reduction and education 
campaigns on risks of 
drug use                                                                     
* Interrupt trajectory into 
problem drug use among 
at-risk young people                                                                    
* Legislate against the 
coercion of minors in the 
supply of drugs 
SP5 - prevent 







cannabis     
Use of










Tusla                         
Dept of 
Children                     
Drug and 
Alcohol Task 
forces                        
HSE                           
Dept of 
Education           
Dept of Justice               





to and delivery 




Goal 2 - 
Minimise the 
harms caused 









community care) & 
reform programme 
2 (citizen master 
plan & health 
regions)                                     
Healthy Ireland 
alcohol policy     
UN Sustainable 
* Develop targeted 
interventions for women 
& expand services for 
pregnant & post-natal 
women                                                          
* Create a path for people 
in rehabilitation to access 
training                                                                                      
* Progress the national 
clinical programme for 
dual diagnosis                                                                                                                             
* Provide advice and 
SP6 - ensure 
access to and 
strengthen 
treatment and 






HSE                            
Drug and 
Alcohol Task 
forces                        





Devt Goal 3 (target 
3.5)                           
assistance to people who 
use drugs and their 
families                                                          
* Recognise the link 
between mental health 
and drug use                                                                                                                 
* Retain Covid-19 
measures to improve 





high risk drug 
users to achieve 
better health 
outcomes 
Goal 2 - 
Minimise the 
harms caused 








inequalities)                           
Housing for All 
Strategy                 
Interagency Group 
for Fairer and Safer 
Ireland                                     
* Develop an inclusion 
health approach for 
people who are homeless 
& in addiction                                                           
* Ensure pathways to 
access treatment for high 
risk groups                                                  
* Increase residential 
treatment & step-down 
accommodation                                     
* Open supervised 
injecting facility                
* Consider the mental 
health and addiction 
challenges of those 
imprisoned                                        
* Retain Covid-19 
measures for people who 
are homeless          * 
Support drug-testing 
services 









use drugs                                             
SP8 - address 
the health and 
social needs 
of people who 




Drug deaths                       
OST service 
users               
Injecting 
heroin use       
Drug-related 
infectious 
diseases          
Single 




HSE                                
Dept of Health              
Civil society                 
Irish Prison 
Service          
Probation 
























Programme                                 
SICAP                                 
Framework Policy 
for Local & 
Community 
Development              
Community safety                         
NEIC & Drogheda 
initiatives           
Traveller health 
action plan       
UBU Your Place 
Your Space    
Roadmap for 
Social Inclusion    
* Ensure a good 
neighbour policy for drug 
treatment centres                                             
* Reduce anti-social 
behaviour and make 
people feel safer in 
communities                            
* Support the Drug 
Related Intimidation 
Reporting Programme                                      
* Expand the NEIC model 
to other comparable 
disadvantaged areas                
* Support role of task 
forces in identify local 



















lead to their 
involvement 





intimidation                 
DRIRP 
referrals         
Dept of Rural 
& Community 
Developement        
LCDC/SICAP 
providers           
Dept of Health                     
HSE                              
Dept of Justice          
Dept of 
Children            
Dept of Social 
Protection                  
Drug and 
Alcohol Task 










Goal 3 - 
Address the 
harms of drug 
markets & 
reduce access 
to drugs for 
harmful use 
Health diversion 
programme         
Youth Justice 
Strategy                
Joint Agency 
Response to Crime                                         
Drug Treatment 
Courts           
Criminal Justice 
Strategic 
Committee                                        
* Health-led approach to 
connect people who use 
drugs with health services 
and to avoid a criminal 
















Dept of Justice           
Dept of Health            
Courts Service                   
Probation 
Service       
Health Service 
Executive                      
An Garda 























actions                  
Chapter 8 - 
strengthen the 
performance 




assessment)          
British Irish 
Council work 
sector on drugs & 
alcohol                  
European 
Monitoring Centre 
for Drugs and Drug 
Addiction                                      
HRB/Reitox 
national focal point                                      
*  Learning the lessons of 


































practice                    
performance 
measurement  
Dept of Health                                 
Drug and 
Alcohol Task 
Forces                         
HSE                               
Civil society              
Academics                 
HRB                       
 
  
 
 
 
